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Summary  
Parasitic helminths are responsible for numerous tropical diseases which represent a major 
health problem in tropical and subtropical regions such as lymphatic filariasis (elephantiasis), 
causing lymphedema in limbs and scrotum in lymphatic filariasis patients and onchocerciasis 
(river blindness) leading to blindness and severe dermatitis in onchocerciasis patients. 
Helminths modulate the immune system of their hosts to their benefit, enabling and 
prolonging parasite survival in the host. On the other hand, several human and animal studies 
confirmed a protective effect of helminth infections and worm extracts on allergic and 
autoimmune diseases and more recently on metabolic diseases such as diet-induced insulin 
resistance. In order to obtain a better understanding of filarial immunomodulation and 
protective immune responses against filariae, the Litomosoides sigmodontis model was used. 
As type 2 immune responses are in general associated with protective immune responses 
against filariae, the present thesis directly assessed the role of eosinophils, IL-5 and IL-4R on 
L. sigmodontis infection. Therefore, wild-type (WT) BALB/c mice and mice deficient for 
eosinophils (dblGATA), IL-5, IL-4R and both IL-5/IL-4R were used. Analyses were 
performed at the peak of microfilaremia (71 days post infection (dpi)) and during a late time 
point of infection (119dpi). Following necropsy parasitological (worm and microfilaria load) 
as well as immunological parameters (cytokine levels, major immune cell types) within the 
thoracic cavity (the site of adult worm residence) and the spleen were analysed. A negative 
correlation between thoracic cavity eosinophil numbers and the adult worm burden as well as 
microfilaremia was observed. Alternatively activated macrophages (AAMs) correlated 
negatively with microfilaremia and positively with the adult worm load, which was associated 
with an extended adult worm survival in dblGATA, IL-5-/- and IL-4R-/-/IL-5-/- mice. Mice 
deficient for IL-4R/IL-5 had the highest susceptibility for L. sigmodontis infection, an earlier 
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onset of microfilaremia, highest microfilariae (MF) loads and an extended adult worm 
survival. Another focus of this dissertation was the role of the damage-associated proteins 
S100A8/A9 during L. sigmodontis infection. S100A8/A9 was shown to provide an anti-
inflammatory effect within the lung during the migratory phase of infective L3 larvae. 
Therefore, S100A8/A9-/- mice exhibited a decreased worm burden, which was associated with 
an increased inflammatory immune response within the lung compared to WT controls. The 
reduced worm burden in S100A8/A9-/- mice was also given following subcutaneous (s.c.) 
infection and the immune response within the skin was not altered in comparison to WT 
controls. The S100A8/A9-mediated protective mechanisms occurred in the lung via 
neutrophils, but not in the skin. Furthermore, the impact of the aryl hydrocarbon receptor, 
belonging to the family of Pattern Recognition Receptors (PRRs), during L. sigmodontis 
infection was analyzed. AhR-/- mice exhibited an increased worm burden, which was 
presumably based on limited protective immune responses within the skin and increased 
vascular permeability, facilitating larval migration and parasite survival. 
The next part of this thesis studied the beneficial immunomodulatory effect of L. sigmodontis 
adult worm extract (LsAg) during diet-induced glucose intolerance and T cell inflammation. 
Repeated intraperitoneal (i.p.) injections of LsAg improved glucose tolerance, but not insulin 
sensitivity in obese mice. The protective effect was associated with a decreased type 1 
inflammation in adipocytes, which represent a main cause of insulin resistance. IFN-γ, TNF 
and IL-17 were decreased in CD4+ T cells in LsAg treated mice. Furthermore TNF and IL-17 
were significantly lower in CD8+ T cells in LsAg-treated animals compared to corresponding 
controls. Our study revealed that filarial extracts present potential candidates to treat diet-
induced insulin resistance. Finally, I contributed to the identification of novel macrofilaricidal 
compounds by in vivo testing in the L. sigmodontis rodent model with several industry 
partners. 
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Zusammenfassung 
Parasitäre Helminthen sind für eine Vielzahl von tropischen Krankheiten verantwortlich, die 
ein großes Gesundheitsproblem in den Tropen und Subtropen darstellen. Bei der 
lymphatischen Filariose (Elephantiasis) leiden Patienten unter Lymphödemen in den 
Gliedmaßen und bei der Onchozerkose (Flussblindheit) unter schwerwiegender Dermatitis 
sowie Blindheit. Helminthen modulieren das Immunsystem ihres Wirtes zu ihrem Vorteil, 
welches das langfristige Überleben des Parasiten im Wirt ermöglicht. Zudem belegen humane 
und tierexperimentelle Studien, dass Helmintheninfektionen und -extrakte Allergien, 
Autoimmunerkrankungen sowie metabolische Krankheiten lindern und sogar verhindern 
können. Neue Therapieansätze gegen Filarieninfektionen, Allergien und 
Autoimmunerkrankungen werden mittels des Models L. sigmodontis untersucht und 
identifiziert. In der vorliegenden Arbeit wurde der direkte Einfluss von Eosinophilen, IL-5 
und IL-4R auf die L. sigmodontis Infektion in WT BALB/c Mäusen und Mauslinien, welche 
defizient für Eosinophile (dblGATA), IL-5, IL-4R und IL-5/IL-4R sind, untersucht. 
Parasitologische sowie immunologische Parameter wurden während des Mikrofilarienpeaks 
(71dpi) und zu einem späten Zeitpunkt der Infektion (119dpi) analysiert. In der Pleuralhöhle 
befindliche Eosinophile korrelierten negativ mit der adulten Wurm- und Mikrofilarienlast. 
Alternativ aktivierte Makrophagen korrelierten ebenfalls negativ mit der Mikrofilarämie, 
jedoch positiv mit der adulten Wurmlast, die mit einer erhöhten Lebenserwartung der adulten 
Würmer in den Eosinophil-defizienten Mauslinien assoziiert war. Dabei konnte festgestellt 
werden, dass die IL-4R/IL5 defizienten Tiere alle MF positiv waren. Zusätzlich wiesen diese 
Tiere die höchste Mikrofilarienlast auf, die zusätzlich mit einer frühzeitigen 
Mikrofilarienfreisetzung assoziert war. 
Des Weiteren wurde im Rahmen dieser Dissertation eine anti-inflammatorische Rolle für 
S100A8/A9 in der Lunge während der L. sigmodontis Infektion nachgewiesen. 
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S100A8/A9-/- Mäuse waren durch eine geringere Adultwurmlast charakterisiert, die zusätzlich 
mit einer verstärkten inflammatorischen Immunantwort in der Lunge im Vergleich zu den WT 
Kontrollen assoziiert war. Subkutane und intradermale Injektionen von infektiösen L3 Larven 
in S100A8/A9-/- Mäusen hatten keinen Einfluss auf die Infektionslast. Dies zeigt, dass 
S100A8/A9-assozierte Immunantworten in der Haut nicht die Wurmlast beeinflussen. Zudem 
konnte gezeigt werden, dass ein durch Neutrophile initiierter protektiver Mechanismus in der 
Lunge stattfindet, da die Depletion von Neutrophilen in der Lunge in einer erhöhten Wurmlast 
in S100A8/A9-/- Tieren resultierte. 
Ein weiterer Teil der Dissertation beschäftigte sich mit dem Einfluss des Aryl Hydrocarbon 
Rezeptors (AhR) auf die L. sigmodontis Infektion. AhR-/- Mäuse waren durch eine erhöhte 
Wurmlast charakterisiert, die vermutlich auf eingeschränkte Immunantworten innerhalb der 
Haut, der Pleuralhöhle sowie einer erhöhten vaskulären Permeabilität zurückzuführen ist.  
Zusätzlich wurde in dieser Thesis der Effekt von adultem L. sigmodontis Wurmextrakt 
während einer Diät-induzierten Glukoseintoleranz auf die Zytokinproduktion von T Zellen 
untersucht. Intraperitoneale Injektionen von LsAg verbesserten die Glukosetoleranz, jedoch 
hatten keinen Einfluss auf die Insulintoleranz in adipösen Mäusen. Dieser protektive Effekt 
war mit einer verminderten Typ 1 Inflammation in den Adipozyten assoziiert. Darüber hinaus 
resultierte die Behandlung mit LsAg in einer verringerten pro-inflammatorischen 
Zytokinproduktion in CD4+ (IFNγ, TNF, IL-17) und CD8+ T Zellen (TNF, IL-17) im 
Vergleich zu PBS behandelten adipösen Kontrolltieren. Zusammengefasst stellen 
Filarienextrakte vielversprechende neue Therapieansätze für die Diät-induzierte 
Insulinresistenz dar. Letztendlich unterstütze ich die Identifizierung neuer makrofilarizider 
Substanzen im L. sigmodontis Nagetiermodell, die in enger Zusammenarbeit mit diversen 
Industriepartnern durchgeführt wurden. 
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1. Introduction 
1.1 Great diversity of parasitism 
Parasitism represents a type of symbiotic relationship between two species, whereupon one 
member, the parasite, benefits at the expense of the host [1]. The word parasite is derived 
from the Latin form of the Greek word “parasites”, implying “one who eats at the table of 
another”. Parasites are found in every taxon, belonging to the most successful and adaptable 
life forms [2]. More than half of all living organisms undergo a parasitic phase at some point 
in their life cycle.  
Many studies in the past have already confirmed that parasites can cause major adverse health 
consequences on their hosts [1, 3], inducing immune or stress responses, or direct deprivation 
of resources [4, 5]. These detriments are usually sub-lethal, but can still influence the fitness- 
related properties of the host negatively [6], impairing movement, behaviour and foraging [7]. 
More than one hundred different types of organisms exist, which exhibit a parasitic phase 
in/on humans, including lice, ticks, mites, fungi, protozoa and helminths. Two major groups 
of parasites exist: (i) The protozoa and (ii) helminths which are further divided into cestodes, 
trematodes and nematodes. Infection with helminths produces debilitating and chronic 
diseases [8, 9] and among the helminths, the nematodes are the most abundant groups of 
invertebrates on earth and therefore, the nematode infections are one of the most prevalent 
infections world-wide. 
1.2 Biology of Nematodes 
Nematodes, also known as roundworms, belong to the phylum Nematoda. They represent a 
manifold group of metazoa and are among the most abundant multicellular animals on earth. 
It is estimated that more than 40.000 species exist, although just half of them have been 
identified and classified. Nematodes account for 80% [10] of all individual animals and occur 
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as parasites in animals, plants or as free living forms in almost every ecosystem, including 
marine and terrestrial environments. Therefore, nematodes play an important role in 
homeostasis, nutrient cycling and release of nutrients, which are for instance crucial for plant 
growth. With reference to the morphology of nematodes, they share numerous similarities 
within this high abundance of species. The morphology of nematodes is simple, consisting of 
an unsegmented bilaterally symmetrical body, which is composed of a hypodermis and a 
longitudinal muscle layer covered by a cuticle. Nematodes range in size, depending on the 
species, from several millimeters up to one meter [11]. They have been described as “a tube 
within a tube”, referring to the alimentary canal which extends from the anterior (head) to the 
posterior end (tail). Nematodes feature several nervous, digestive, excretory and reproductive 
systems, but lack a respiratory system. Most species possess two sexes, but some are 
hermaphroditic, which are characterized by featuring male and female reproductive organs in 
the same individual. Sexual size dimorphism occurs in most of the species, resulting in 
increased length of female worms compared to male worms. Research has been focused on 
the parasitic forms due to their veterinary (domesticated animals, cattle-breeding), economic 
(crop plants) and medical importance. It is estimated that approximately 138 nematode 
species occur in humans [12]. Parasitic nematodes (hookworm, lungworm, pinworm, 
eelworm, and threadworm) occur mostly within the host at the circulatory, respiratory and 
alimentary systems. They are the mediators for several devastating diseases, such as 
lymphatic filariasis and onchocerciasis. Onchocercidae represent a family of nematodes, 
commonly termed as threadworms (~ 600 species) in the superfamily Filarioidea. These 
helminths belong to one of the major groups of human pathogenic parasites, being responsible 
for disabling diseases such as onchocerciasis, lymphatic filariasis or loiasis [13, 14]. 
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1.3 Helminth infections: beneficial or harmful? 
Although, the role of helminths in the incidence of infectious diseases is well established, 
there is unequivocal epidemiological data showing reduced incidence of allergies [15-17] and 
autoimmune diseases [18, 19] in regions with a high prevalence of helminth infections. 
Parasitic helminths are multicellular eukaryotic invertebrates, which have adapted to their 
host and developed diverse mechanisms to facilitate their maintenance and long term survival 
within the host, as “masters of regulation” [20, 21]. Long-term survival within the host is 
achieved by extenuating type 1 immune responses and eliciting a predominant type 2 immune 
milieu [20, 22]. During the last decades the incidence of infectious diseases decreased 
significantly due to improved standard of living, sanitation and medical progress. Therefore 
helminth infections mostly occur nowadays in the tropical and subtropical countries, affecting 
mainly the poor parts of the population [23-25]. 
In the past, several studies have shown a “beneficial” impact of helminth infections. 
Helminth-derived immunomodulatory products such as the small molecule analogs (SMA) of 
the excretory-secretory product 62 (ES-62) represent potential new therapeutic approaches to 
treat autoimmune and allergic symptoms, including experimental arthritis [26], systemic lupus 
erythematosus (SLE) [27], skin and lung allergy [28], type 1 diabetes (T1D) [29-32] and type 
2 diabetes (T2D) [30, 33, 34]. Nevertheless helminths are also responsible to mediate several 
severe diseases such as lymphatic filariasis caused by Wucheria bancrofti, Brugia malayi, 
Brugia timori and onchocerciasis caused by Onchocerca volvulus. These diseases stigmatize 
the affected individuals by causing lymphedema in limbs (elephantiasis) and scrotum 
(hydrocele) in lymphatic filariasis patients and causing blindness and severe dermatitis in 
onchocerciais patients [8, 35-38]. Due to the chronic nature of these diseases and the inability 
of the affected patients to work, onchocerciasis and lymphatic filariasis represent a huge 
socio-economic problem [8, 35].  
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Furthermore, several studies demonstrated that helminth infection may increase the 
susceptibility of diverse diseases like malaria [39], HIV (human immunodeficiency virus) 
[40] and tuberculosis [41] and also impair vaccine responses [42, 43]. 
1.4 Mass drug administration (MDA) 
As human-pathogenic filarial nematodes can cause debilitating diseases that stigmatize the 
affected individuals with vision impairment, blindness and severe dermatitis in onchocerciasis 
patients [44], lymphedema in limbs (elephantiasis) and scrotum (hydrocele) in lymphatic 
filariasis patients [8], mass drug admininistration programs were started to contain them. Both 
diseases represent neglected tropical diseases and it is estimated that around 120 million 
people are infected with filariae that cause lymphatic filariasis and an additional 17 million 
people suffer of onchocerciasis [45, 46]. The control of onchocerciasis and lymphatic 
filariasis solely relies on the repeated mass drug administration programs (MDAs) of 
ivermectin (IVM) exclusively for onchocerciasis patients and IVM plus albendazole (ALB) 
for lymphatic filariasis in Africa and diethylcarbamazine (DEC) plus ALB for lymphatic 
filariasis outside of Africa [8, 35]. The elimination of both diseases is hampered due to a lack 
of macrofilaricidal efficacy of IVM and DEC, which only temporarily inhibit the 
embryogenesis of female adult worms [8, 47]. Thus, these MDAs have to be given (bi-) 
annually for multiple years for the reproductive life span of the adult worms (onchocerciasis 
~15 years) (lymphatic filariasis ~5 years), which depicts a huge challenge for health care 
systems [8]. 
New therapy approaches recommended by the WHO focus on a triple administration of DEC, 
IVM and ALB, resulting in a complete clearance of MF for a period of minimum two years 
[48], which may accelerate the elimination of lymphatic filariasis in specific countries non-
endemic for onchocerciasis (outside of Africa) given an equable population coverage of >65% 
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[48, 49]. This clearance was associated with a decrease of circulating filarial antigen levels, 
which indicates a macrofilaricidal effect [50]. A recent study conducted in Papua New Guinea 
could show that a single regimen of a triple combination of IVM, DEC and ALB was able to 
clear significantly microfilaria from the blood for 3 years [48]. However, modelling studies 
predict impaired efficacy by the reduction of MDA rounds in areas of lower endemicity of 
lymphatic filariasis [49]. Nevertheless, reduced MDA rounds in areas of lower prevalence of 
onchocerciasis and lymphatic filariasis will improve the cost-effectiveness of community-
based MDA programs [51]. Furthermore, it has to be taken in consideration that multiple drug 
administration’s (triple therapy) [52] always harbor potential risks of upcoming resistance and 
of causing severe adverse events (SAE) in co-infections for instance in Africa with 
onchocerciasis and Loa loa [53]. SAE occur due to excessively rapid MF elimination by IVM 
in Loa loa-infected patients and during DEC treatment in onchocerciasis-infected patients. [8, 
52, 54-56]. Therefore novel alternative strategies, including the further identification of new 
compounds eliciting macrofilaricidal or adult-worm sterilizing efficacy, should be developed 
and established [51, 57]. 
1.5 Wolbachia- a new promising target for filarial therapy 
Wolbachia are common gram negative intracellular alpha-proteobacterial endosymbionts of 
terrestrial arthropods and nematodes, which belong to the order Rickettsiales. Most 
arthropods, including the majority of insect species, arachnidas, crustaceans and nematodes 
possess Wolbachia [58-60]. However, some filarial species do not harbor Wolbachia, for 
instance the rodent nematode Acanthocheilonema viteae [59] or the human pathogenic filaria 
Loa loa [61]. In arthropods they behave as reproductive parasites, whereas in nematodes they 
are mutualist symbionts, playing an essential role for filarial survival, fertility and larval 
molting [9, 37, 47, 62-65]. In filarial nematodes different strains of Wolbachia have been 
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classified into different super groups (C, D, J, and F) [66, 67]. Several studies have confirmed 
that Wolbachia are found primarily in the reproductive tract of adult female worms and in the 
hypodermis [68] including all life cycle stages (L1, L2, L3, L4, male and female adult worms) 
[59, 66, 69, 70] even in embryos, which are then transmitted transovarially [71, 72]. The 
density of Wolbachia diversifies depending on the colonized tissues and development stage. 
Therefore, MF (L1 larvae) possess less Wolbachia compared to higher larval (L2, L3, L4) and 
adult stages [70]. Interestingly, Wolbachia may induce inflammatory responses within the 
filariae-infected host [73-75], through TLR2/TLR6 activation [75], inducing Th1 cytokines 
such as TNF, Interleukin-6 (IL-6), IL-1β, IFN-γ, and IL-2, while reducing anti-inflammatory 
mediators such as Tregs, IL-10 and TGFβ [76, 77]. Wolbachia have been identified as a new 
promising target for anti-filarial therapy [60]. Depletion of Wolbachia with doxycycline or 
rifampicin leads to permanent sterilization of O. volvulus female adult worms and adult 
filariae causing lymphatic filariasis and result in a slow elimination of the adult worms [63, 
78-81]. Recent studies have shown that Wolbachia provide essential metabolites and 
nucleotides and support the development and survival of the filariae [36, 82-84]. However, 
doxycycline is contraindicated for pregnant or lactating women and children below the age of 
8 and has to be given at least for four to six weeks to achieve a permanent sterilization or 
macrofilaricidal efficacy [47, 54].  
Collectively, there is a crucial demand for novel drugs and alternative treatments, which 
directly target adults and permanently impair filarial fertility and survival. New therapies, 
ideally as oral formulation or by a single parenteral administration, could contribute to the 
elimination of those filarial diseases and would allow their application in areas with upcoming 
drug resistance and in areas of onchocerciasis and/or Loa loa co-endemicity, avoiding severe 
adverse events due to the use of microfilaricidal drugs. 
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1.6 The Hygiene Hypothesis 
During the last decades epidemiological studies confirmed an increased incidence of allergies 
such as dermatitis, rhinitis, asthma [85, 86], and autoimmune diseases, for instance 
rheumatoid arthritis, multiple sclerosis (MS), chronic inflammatory bowel disease and T1D in 
developed countries compared to developing countries [25, 29, 31, 86, 87]. Interestingly, 
there is an inverse correlation between the prevalence of helminth infections and the 
occurrence of allergies and autoimmune diseases [86], since the number of helminth-infected 
patients decreased significantly due to improved hygiene, sanitation and medical progress 
over the past decades in developed countries [24, 88]. Based on those observations the 
hygiene hypothesis was developed and states that a lack of infections during childhood results 
in an impaired adaptive immune system, favoring the development of allergies. Accordingly, 
children infected with Schistosoma mansoni [89-91] and Schistosoma haematobium are less 
prone to develop allergies [15, 16] and studies performed in areas with a low level of 
sanitation and a high prevalence of intestinal helminth infections (hookworm) revealed a 
decreased skin sensitization in children [17]. In addition, it has been shown that MS 
prevalence and progression was reduced by helminth infections [18, 19]. Interestingly, the 
clearance of helminth infections abrogated this helminth protective induced effect and 
resulted in an increased pathology [15, 92-94] and disease incidence [95, 96]. 
1.7 Diabetes- health challenge of the 21st century 
In light of the emerging evidence that helminths protect against type 2 diabetes, the current 
deworming programs or MDAs against helminths in combination with other conventional risk 
factors might contribute to the development of diabetes [97]. Diabetes represents the fastest 
increasing long-term disease of the 21st century that affects millions of people worldwide, 
depicting a huge health problem.  
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The International Diabetes Federation (IDF) reported that around 387 million people were 
suffering from diabetes in 2014. This number is expected to increase up to 642 million 
patients by 2040. Around 90% of patients suffering from diabetes are due to T2D. Diabetes is 
a chronic metabolic disease impairing the production (T1D) or the sensitivity (T2D) to 
respond to the hormone insulin, resulting in elevated blood glucose levels [98]. T1D 
(autoimmune diabetes) has its onset commonly during childhood and is caused by the 
destruction of insulin-producing pancreatic β-islet cells by autoreactive T cells, wehereas T2D 
(metabolic diabetes) occurs during adulthood by decreasing insulin sensitivity. Insulin 
resistance is highly associated with ageing, obesity and physical inactivity [98]. The risk to 
develop T1D is strongly dependent on genetic and environmental criteria, whereas in T2D the 
life style and alimentation significantly influences T2D development.  
Diabetes increases the risk of severe macrovascular (cardiovascular) and microvascular 
(retino- and nephropathy) blood vessel damage and therefore, severe heart diseases, eye, 
kidney and nerve damages [99, 100]. Furthermore, recent studies demonstrated an association 
between diabetes and several types of cancer [99-101]. 
Obesity is responsible for numerous chronic diseases, such as cardiovascular diseases, cancer 
and diabetes in high, middle and low-income countries. Recent papers have indicated an 
essential link between functional changes of innate immune cells during inflammation and 
insulin resistance [102]. In general, obesity leads to chronic inflammation and alterations of 
the cellular composition of the adipose tissue. Therefore, adipose tissue of slim individuals 
mainly constitutes of high frequencies of type 2-associated and anti-inflammatory, regulatory 
cells including eosinophils, AAMs, Th2 cells and Tregs. However, during obesity adipocytes 
increase in size and undergo apoptosis [103, 104] due to adipose tissue hypoxia [105, 106], 
which provides an inflammatory stimulus, leading to the infiltration of inflammatory cell  
 13 
 
types such as CD8+ T cells and classically activated macrophages and a reduction of 
eosinophils and Tregs. Interestingly, recent studies highlighted an essential role of T cells 
during several processes between the adaptive immune system and obesity-induced systemic 
metabolic dysfunctions as well as insulin resistance [107, 108]. Inhibition of the insulin 
signaling cascade results in an impaired glucose uptake. Besides, it was also shown that the 
depletion of CD8+ T cells alleviated adipose tissue inflammation in obese mice and improved 
insulin resistance [109, 110]. Despite these findings less is known about the 
immunomodulatory capacity of T cells during obesity. high fat diet (HFD) induced obesity in 
mice is associated with a constantly increasing cell number (hyperplasia) and size of 
adipocytes (hypertrophy) [111], lipid accumulation and increased body weight. Adipocyte 
hypertrophy and hypoxia [105, 106] represent the most important mediators for local adipose 
tissue inflammation. This inflammation is associated with an increased production of several 
chemokines such as Regulated And Normal T cell Expressed and Secreted (RANTES), 
monocyte chemotactic protein 1 (MCP-1), cytokines (IL-6, TNF) and apoptosis, which further 
induce the infiltration of inflammatory cell types such as classically activated macrophages 
enhancing inflammation [112] and inhibiting the insulin signalling cascade [113, 114]. 
Accordingly, an inverse association between helminth infection and diabetes was observed in 
several human studies [115, 116]. Further animal studies showed that helminth infection or 
the repeated administration of crude adult worm extracts (LsAg) or helminth-derived products 
improve diet-induced insulin resistance [117, 118], which was associated with regulatory 
immune responses and a type 2 immune shift and counter-regulated inflammatory type 1 
immune responses, leading to an immunoregulatory phenotype with an expansion of AAMs, 
eosinophils, regulatory T cells, type 2 innate lymphocytes (ILC2s) in the adipose tissue [30, 
119]. 
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A number of reports have shown that helminth infections, their extracts and products were 
able to prevent diabetes in a murine model of T1D (non-obese diabetic (NOD) mice). Extracts 
of adult S. mansoni as well as its eggs demonstrated a decreased T1D disease incidence and 
perpetuated islet cells [120]. Another study demonstrated that worm products from Fasciola 
hepatica were also shown to prevent the onset of diabetes, by peritoneal AAMs driven 
immune responses, which posesses the capacity of inducing a potent Treg response [121]. In 
regard to nematodes, Hübner et al. illustrated that the filarial model L. sigmodontis using L3 
larvae, adult worms or LsAg protected NOD mice in developing T1D due to the generation of 
a Th2 immue responses as well as Treg responses [31]. However, it has to be noted that worm 
products and helminth belonging to different species may elicit different mechanism and 
therefore, revealing no beneficial impact in certain diseases like T1D. ES-62 represents a 
glycoprotein, which is derived from the filarial nematode Acanthocheilonema viteae. 
Prophylactical and therapeutical approaches by ES-62 have been reported in several diseases, 
such as SLE [122] and asthma [123, 124]. Nevertheless ES-62 or its synthetical SMAs were 
shown to have no impact on T1D development in NOD mice, suggesting a different 
mechanism of action. It seems to be more suitable as prophylactical and therapeutical therapy 
in strong systemic inflammatory diseases, instead in diseases with dominating organ-specific 
pathology [125]. Recent work of our group demonstrated (Surendar et al. submitted) that 
repeated i.p. administration of LsAg led to an increase of adipose tissue released adiponectin, 
a protein hormone produced by adipocytes and involved in numerous metabolic processes 
(glucose regulation, fatty acid oxidation) [126, 127]. Interestingly, other studies have shown 
that adiponectin in combination with leptin reverses insulin resistance in mice [128] and 
obesity as well as adiponectin concentrations are inversely correlated [127, 129, 130]. 
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1.8 Calprotectin- S100A8/S100A9 
Studying the protective effects of helminths in metabolic and autoimmune diseases can lead to 
helminth-based therapies. However, it is also important to better understand their mechanisms 
of pathogenesis in case of the tropical diseases caused by them. In this context, the role of L. 
sigmodontis infective larvae in early pulmonary phase of infection is recently being studied 
extensively. The recruitment of neutrophils along with an increase in the S100A8 and S100A9 
proteins has been shown as the mechanism behind the pulmonary inflammation. Another 
recent study demonstrated that infective L. sigmodontis L3 larvae trigger pulmonary 
inflammation, which was associated with neutrophil recruitment, increased lung pathology as 
well as increased concentrations of S100A8/S100A9 in the bronchoalveolar lavage [131]. 
These results indicate Calprotectin (S100A8/S100A9) as potential marker of inflammation 
with an essential role on the outcome of filarial infection. Tissue injuries or infections result 
in a marked increase and release of damage-associated proteins from the S100 protein family 
[132-134]. These alarmins bind and activate damage-associated molecular patterns (DAMPs) 
via Toll-like receptor 4 (TLR4) [135, 136], a receptor for advanced glycation endproducts 
(RAGE) [137], heoaran sulphate proteoglycans (HSPG), G-protein coupled [138], scavenger 
[139], epidermal growth factor (EGF) [140], Gaq-coupled [141], human epidermal growth 
factor receptor 2 (HER2) [142], fibroblast growth factor receptor 1 (FGFR1) [143], dependent 
mechanism and function as early amplifiers of acute and chronic inflammatory immune 
responses [132, 136].  
The S100 protein family has been shown to play a key role during the regulation of various 
cellular processes such as calcium homeostasis, cytoskeletal dynamics, transcription factors, 
enzymatic activities, phagocytosis activity, chemotaxis (neutrophils, monocytes, and 
macrophages), cell growth, survival and differentiation.  
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Currently 25 S100 proteins have been identified and two prominent members of the protein 
family (S100A8 and S100A9) constitute the heterodimer Calprotectin [144] (MRP8/MRP14). 
Calprotectin elicits a major role during inflammatory conditions [145] such as in numerous 
autoimmune diseases, neurodegenerative disorders, atherosclerosis and several types of 
cancer [145-148]. However, there is still a controversy ongoing whether calprotectin is 
pathogenic (pro-inflammatory) or protective (anti-inflammatory) [149]. S100A8 and S100A9 
are constitutively expressed in circulating neutrophils and monocytes [133] with reduced 
expression levels during cell differentiation and maturation. Both proteins are released during 
infection, tissue damage, cellular necrosis, formation of neutrophil extracellular traps (NETs) 
[150] and can be also secreted passively [132, 133, 151]. 
1.9 Aryl hydrocarbon receptor 
The aryl hydrocarbon receptor (AhR) represents a transcription factor in the pattern 
recognition receptor (PRR) group and belongs to the family of basic helix-loop-helix/PAS 
(bHLH PAS). It plays an important role in the sensing of environmental changes and is 
widely abundant in the immune system, including peripheral immune organs such as spleen 
and lymph nodes. Furthermore, AhR is highly expressed in mature immune cells at barrier 
sites (Th17, Tregs, γδ T cells, macrophages, dendritic cells) such as in the skin [152, 153], 
lung, liver and gastrointestinal tract [154]. AhR acts as environmental sensor ensuring 
immunosurveillance and primary defence against external harmful factors.  
In the absence of a ligand, AhR is retained in an inactive complex located in the cytoplasm 
bound to actin filaments, consisting of various chaperone proteins such as heat shock protein 
90 (HSP90) [155], AhR-interacting protein (AIP) [156, 157] and p23 [158]. HSP90 and p23 
have been shown to be involved in DNA and ligand binding. Binding of a ligand results in a 
complex activation and therefore to a translocation into the nucleus [159], where AhR is 
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released from the complex and forms a heterodimer with its protein partner aryl hydrocarbon 
receptor nuclear translocator (ARNT) [160]. Afterwards AhR/ARNT binds to genomic 
regions containing its binding motif dioxin response element (DRE) [161] and leads to the 
expression of target genes for instance CYP1A1, CYP1A2, CYP1B1 and AhR repressor 
(AhRR) [161, 162]. 
 
 
 
 
 
Fig. 1: The aryl hydrocarbon receptor pathway. In its inactived form AhR is bound to actin filaments in the 
cytoplasm and forms a complex with various chaperone proteins, such as HSP90, p23 and AIP. Binding of a 
ligand leads to translocation of the complex into the nucleus, where AhR is released from the complex and 
forms a heterodimer with its protein partner ARNT and binds to genomic binding motif regions (DRE). 
Afterwards target genes are expressed for instance as CYP1A1, CYP1A2, CYP1B1, and AhR repressor (AhRR). 
AhR signaling is regulated by AhR/ARNT complex disruption via AhRR, proteasomal degradation of AhR 
and ligand metabolism by CYP1A1 [163]. 
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Besides, the multifunctional roles of AhR on the immune response, several studies 
demonstrated an essential role of AhR in the recognition and elimination of invading 
pathogens. AhR has been shown to be responsible for the orchestration of specific 
inflammatory immune responses towards the pathogen and therefore, reducing 
immunopathology to the host [164]. For instance AhR provide protection during 
enteropathogenic bacterial infection by its regulatory capacity on Th22 cells or more 
specifically on their IL-22 production [165, 166]. Furthermore, other reports highlighted that 
bacterial infections in AhR-/- mice with Streptococcus pneumonia [167] (extracellular 
pathogen) as well as Listeria monocytogenes (intracellular pathogen) [168] resulted in 
increased pathogen susceptibility. Interestingly, another report illustrated a regulatory 
property by AhR signaling in hematopoietic and non-hematopoietic compartments to the 
antibacterial response, revealing an important involvement of macrophages and neutrophils 
during Pseudomonas aeruginosa infection [169]. Due to the fact that AhR-/- mice are 
characterized by reduced numbers of skin and gut intraepithelial lymphocytes [170] as well as 
intestinal innate lymphoid cells (ILCs), it can be speculated that absence of AhR impairs 
immune responses within these barriers. Impaired immune responses facilitate pathogen 
invasion and lead to an increased susceptibility, which was further observed during 
Citrobacter rodentium infection [171, 172]. Although AhR is highly expressed in barrier 
sites, which are the entry points for helminths, nothing is known about its role during 
helminth infections.  
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1.10 L. sigmodontis: a laboratory rodent filariae model to investigate immune responses 
during filariasis 
L. sigmodontis represents an excellent laboratory model to investigate parasitological and 
immunological responses during filarial infection [173-176]. BALB/c mice are susceptible to 
L. sigmodontis infection and the filariae can undergo its full life cycle under laboratory 
conditions [173, 177], whereas in C57BL/6 mice filarial development is impaired, leading to 
accelerated elimination of adult worms around 35dpi and to complete absence of MF [178]. 
Previous studies showed that the L. sigmodontis mouse model helped us to obtain a better 
understanding of the filarial immunomodulation [179, 180] and involved protective immune 
responses, since immunocompetent laboratory mice are non-permissive and exhibit high 
resistance to human pathogenic filariae (Brugia spp, Onchocerca spp) [178]. The L. 
sigmodontis mouse model in BALB/c, C57BL/6 and immunodeficient mice was used to 
identify and study local and time dependent immune responses during filarial infection [174, 
181-185]. L. sigmodontis-infected mice develop immune responses that resemble those of 
human filarial infections. During human filariasis patients develop type 2 immune response 
including eosinophilia and the release of eosinophil-associated molecules, increased 
production of type 2 cytokines such as IL-4 and IL-5 [186], elevated numbers of innate 
lymphocyte cells [187], as well as polarisation of classical activated macrophages into AAMs 
[188]. Human filariasis is further associated with regulatory immune responses that suppress 
both type 1 and type 2 immune responses due to the induction of IL-10 and expansion of 
regulatory T cells (Tregs) [189-191]. Those type 2 immune responses are linked to protection 
and the development of filarial pathology in patients with onchocerciasis [192, 193]. For 
instance some patients with onchocerciasis develop hyperreactive symptoms with severe skin 
disease and those exhibit strongest type 2 immune responses, which are associated with 
reduced MF levels [180, 194].  
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Similar observations were made in patients with lymphatic filariasis, whereas only 50% of 
patients develop microfilaremia. Those patients exhibited increased adaptive immune 
responses and elevated parasite-specific IL-5 levels [195]. On the other hand lymphedema has 
been associated with pronounced parasite-specific Th1 and Th17 responses [196].  
In the L. sigmodontis model impaired type 2 immune responses due to the absence of essential 
cell types such as eosinophils, including eosinophil products like eosinophil peroxidase (EPO) 
and major basic protein (MBP) resulted in an increased L. sigmodontis worm burden. 
However, no development of MF occured in semi-resistant 129/SvJ background mice [182]. 
Mice deficient for eosinophil-associated chemokines such as Eotaxin 1 exhibited an increased 
L. sigmodontis adult worm burden [197]. Similar results were observed in IL-5 deficient mice 
due to the essential role of this type 2 cytokine, which is crucial for the differentiation and 
maintenance of eosinophils during L. sigmodontis infection. Furthermore, several studies 
illustrated a protective role of IL-4 during L. sigmodontis infection as semi-resistant C57BL/6 
mice develop patent infections in the absence of IL-4 [183, 198]. It was shown that IL-4 
deficient BALB/c mice exhibit increased MF levels compared to WT controls [183, 199]. 
Chronic helminth infections are known to establish an anti-inflammatory milieu within their 
host by increasing the frequency of regulatory T cells, AAMs and certain inhibitory cytokines 
such as IL-10 and/or TGFβ. Therefore, the absence of IL-4 may impair worm survival since 
IL-4 and IL-13 represent crucial mediators and play an essential role in the development of 
AAMs. Recent studies have shown a positive correlation between L. sigmodontis adult worm 
numbers and total counts of AAMs [200]. Interestingly, numerous studies have proven a 
beneficial impact of L. sigmodontis infection on allergic sensitization in asthma [201], type III 
hypersensitivity [202], vaccine modulation [203, 204] and T cell responses [205-207].  
 
 21 
 
With regard to the immunmodulatory capacity of L. sigmodontis, repeated administrations of 
LsAg or infection with L. sigmodontis have been shown to provide a protective impact against 
T1D [29, 31, 208] and to ameliorate glucose tolerance in diet-induced obese mice [118]. 
Interestingly, in E. coli-induced sepsis, pathology was diminished during L. sigmodontis 
infection [209]. Besides, in co-infection models it was shown that L. sigmodontis led to a 
reduced mortality during Plasmodium berghei infection in mice [210] and was able to 
alleviate the pathology in Mycobacterium tuberculosis infected cotton rats [211]. In addition, 
L. sigmodontis has proven its excellent applicability for the screening and identification of 
potential anti-filarial drug and vaccination candidates as surrogate model for lymphatic 
filariasis and onchocerciasis [47, 79]. 
1.11 Life cycle of the murine filariae L. sigmodontis 
The natural host of L. sigmodontis is the cotton rat (Sigmodon hispidus). Gerbils (Meriones 
unguiculatus) and BALB/c mice can be utilized as alternative hosts [173, 178]. L. sigmodontis 
is transmitted by an arthropod vector, the tropical rat mite (Ornithonyssus bacoti), which 
represents the obligate intermediate host. L1 stage larvae also known as MF molt within the 
mite to L2 (6-7 days) and infective L3 larval stages (10-12 days). During the blood meal of 
the vector, infective L. sigmodontis L3 larvae are transmitted into the host’s skin, where they 
migrate via the blood and lymphatic system. After traversing the pulmonary capillaries L3 
larvae reach the thoratic cavity, which represents the site of infection, where the filariae 
finally reside. Recently, it was demonstrated that L. sigmodontis migrating L3 larvae trigger a 
pulmonary inflammatory phase which is characterized by haemorrhages and granulomas due 
to endothelium and parenchyma damage. This transient lung inflammation was further 
associated with an elevated expression of S100A8/S100A9 in neutrophils [131]. Until 6dpi 
most of the L3 larvae reach the pleural cavity. Subsequently, L3 larvae will molt into L4 
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larval stages (8-12dpi). Around 30dpi L4 larvae molt into adult male and female worms, 
which can be differentiated by sexual (vulva or the spicule) and morphological dimorphisms 
(adult worm length: females 10-12cm, males 3-5cm). Adult worms reside within the pleural 
cavity for several months. Subsequent mating leads to the release of MF (80µm length), 
which enter the peripheral blood system from 50dpi [173, 178]. During the next blood meal 
MF are ingested by the mite vector and the life cycle starts over. 
 
 
 
 
Fig. 2: Laboratory life cycle of Litomosoides sigmodontis. During the blood meal of the intermediate 
arthropod host (Ornithonyssus bacoti), infective L3 larvae are transmitted into the murine host’s skin. 
Larvae migrate via the blood and lymphatic system, passing the lung and reaching the site of infection, the 
thoracic cavity around 2-6 days post infection (dpi). Within the pleural cavity L3 larvae molt into L4 stages 
between 8-12dpi and then into adult worms around 30dpi. 50dpi fertilized female worms release their 
progeny (microfilariae) into the peripheral blood system [212]. 
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1.12 Objectives of this thesis  
A – Evaluation of protective immune responses during L. sigmodontis infection  
Parasitic helminths are known to dampen type 1 specific immune responses and create a type 
2 driven and regulatory milieu. Impaired type 1 and type 2 immune responses have been 
shown to increase parasite longevity and fertility. In this thesis the direct impact of 
eosinophils, IL-5, IL-4R, Aryl hydrocarbon receptor (AhR), and Calprotectin 
(S100A8/S100A9) during infection with the murine filarial nematode L. sigmodontis was 
investigated. To obtain a better understanding of the immunology involved and interaction 
between parasite and host, different mouse strains deficient for eosinophils (dblGATA), IL-5, 
IL-4R, IL-4R/IL-5, AhR and S100A8/100A9 were infected via different routes with L. 
sigmodontis; naturally (nat.), subcutaneously (s.c.), intravenously (i.v.), or intradermally (i.d.). 
To further determine protective immune responses, parasitological (parasite burden) and 
immunological (cytokine analysis, quantification of major immune cell types, histology) 
parameters at different time points post infection were analysed to allow conclusions on the 
role of these immunological components on L. sigmodontis infection.  
B – Anti-inflammatory role of filarial extracts (LsAg) on T cell inflammation during 
diet-induced insulin resistance 
Numerous epidemiological studies demonstrated an inverse relationship between allergies and 
infections. It is postulated that the loss of helminth infections and their beneficial 
immunomodulatory abilities due to improved hygiene, sanitation and medical progress led to 
an increased incidence of allergies and autoimmune diseases. A new approach to treat these 
diseases is the development of therapies based on filarial extract products and antigens. 
Worm-derived products have been shown to exhibit anti-inflammatory properties in the 
treatment of rheumatoid arthritis, multiple sclerosis, chronic inflammatory bowel disease 
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(IBD) and T1D. However, the impact of filarial infections and crude worm extracts on 
metabolic diseases like diet-induced insulin resistance is barely known.  
Therefore, the next aim of this thesis was to investigate whether administration of LsAg 
protects against HF diet-induced insulin resistance in DIO mice by modulating T cell 
responses. Obesity is associated with a Th1-driven milieu and correlates with decreasing cell 
frequencies of Tregs, Th2 cells, AAMs and increased frequencies of classically activated 
macrophages, CD8+ T cells and pro-inflammatory cytokines. Thus, we hypothesized a 
reduction in the pro-inflammatory immune responses due to the anti-inflammatory properties 
of LsAg, which have been shown to improve glucose tolerance. 
In summary, this project was performed to investigate the direct impact of LsAg on insulin 
sensitivity in DIO mice, to identify potential novel treatments and protective mechanisms 
against metabolic diseases such as diet-induced insulin resistance. 
C – Identification of macrofilaricidal drug candidates 
The control of lymphatic filariasis and onchocerciasis relies on the repeated administration of 
drugs (MDA) that solely target the filarial offspring, the MF, and temporarily inhibit the 
embryogenesis of adult female worms. Hence, these treatments have to be given on an annual 
to bi-annual basis for the reproductive lifespan (several years) of the female adult worms. 
Therefore, current efforts to eliminate filarial diseases are hampered by the lack of 
macrofilaricidal drugs. New drugs are required for the elimination of those filarial diseases. In 
collaboration with industry partners such potential candidates were identified using the L. 
sigmodontis rodent model.  
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2. Materials & Methods 
2.1 Ethics Statement 
Animal housing conditions and the procedures used in this work were performed according to 
the European Union animal welfare guidelines. All protocols were approved by the 
Landesamt für Natur, Umwelt und Verbraucherschutz, Cologne, Germany (87-
51.04.2010A335, 84-02.04.2014.A327, 84-02.04.2016.A331 and 84-02.04.205.A507).  
2.2 Mice 
All animals (Mus musculus) were bred at the animal facilities of the University Hospital of 
Bonn (House for Experimental Therapy and the Institute for Medical Microbiology, 
Immunology and Parasitology, IMMIP) according to animal welfare guidelines and housed 
during the experiments at the animal facility of the IMMIP. Mice were kept, at 22°C in a 12h 
day-night cycle, in individually ventilated cages. All animals were provided free access to 
food pellets and water ad libitum. Experiments in this thesis were performed using following 
animal genotypes: BALB/c WT and IL-4R-/- mice, which lack the signaling via the IL-4R, 
which responds to IL-4 as well as IL-13, (BALB/c-Il4ratm1Sz/J) were purchased from Janvier 
(Saint-Berthevin, France) and Charles River (Erkrath, Germany), respectively. dblGATA 
BALB/c mice were originally obtained from The Jackson Laboratory (Bar Harbor, Maine, 
USA), IL-5-/- and IL-4R-/-/IL-5-/- BALB/c mice from Prof. Dr. Klaus Matthaei (Matthaei, 
Stem Cell & Gene Targeting Laboratory, ANU College of Medicine, Biology and 
Environment), which lack eosinophils. 
S100A8/A9-/- C57BL/6 mice were kindly provided from Prof. Dr. Thomas Vogl (Institute of 
Immunology, University of Münster, Germany). Corresponding C57BL/6 WT control mice 
were purchased from Charles River (Erkrath, Germany). AhR-/- and C57BL/6 WT control 
mice were obtained from the Life & Medical Sciences Institute (LIMES) (Prof. Dr. Irmgard 
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Förster, University Bonn, Germany). For diet-induced insulin resistance experiments, male 
C57BL/6 (WT) mice were used (Charles River, Erkrath, Germany). HFD, consisting of 60% 
of calories from fat, was acquired from Research Diets (Inc. Brogaarden, Denmark). HFD was 
started at 6-8 weeks of age for a total duration of 18 weeks. For all experiments, age and sex-
matched mice were used. 
2.3 Euthanasia of mice 
At determined time points mice were euthanized per inhalation of an overdose of Isoflurane 
(1-cloro-2,2,2-trifluoroethyldifluoro-methylether; Forene®, Abbolt, Wiesbaden) in a sealed 
plastic box. Afterwards mice were examined for vital signs and reflexes to assure exitus. 
Euthanasia of BALB/c WT, IL-4R-/- (BALB/c-Il4ratm1Sz/J), dblGATA, IL-5-/- and IL-4R-/-
/IL-5-/- was performed on 71 and 119dpi. Necroscopsies of S100A8/A9-/- and corresponding 
C57BL/6 control mice were performed on 12 and 29dpi. AhR-/- and C57BL/6 mice were 
euthanized and analyzed on 5 and 12dpi. For diet-induced insulin resistance experiments male 
C57BL/6 mice were euthanized after 4 weeks of repeated administration of LsAg after 18 
weeks of HFD. 
2.4 Life cycle Litomosoides sigmodontis 
The life cycle of the filarial nematode L. sigmodontis as well as the infection of the animals is 
maintained and performed in an isolated area of the animal facilities of the IMMIP. 
Ornithonyssus bacoti, the tropical rat mite, is used as an obligate intermediate host. Breeding 
of mites were performed in plastic basins covered with fine litter, in incubators at 28°C and 
80% air humidity to mimic the natural environmental conditions of the mites. Feeding of 
mites with fresh blood was performed thrice a week.  
The life cycle of L. sigmodontis is maintained by placing the mites to its natural host, the 
cotton rat (Sigmodon hispidus). Cotton rats were periodically examined for MF load in the 
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peripheral blood. A small portion of blood taken from the orbital vein was used to determine 
MF numbers. During infection, the fine litter containing mites was mixed and transferred to 
special mite basins, whereupon a cotton rat was centrally placed, completely surrounded by 
the fine litter. Thereupon, uninfected mites fed on the MF containing blood of the cotton rats, 
leading to infection of the mites. Subsequently, fed mites leave the cotton rat and return to the 
fine litter, covering the surface of the basin. Afterwards, the fine litter was congregated in a 
glass Erlenmeyer-flask and covered with an artificial polyamide gaze. The flasks were placed 
in basins filled with soap water and stored in the incubator. After completing the infection, the 
cotton rat was returned to the plastic basin, covering the surface with soap water in order to 
remove remaining mites. The following day, cotton rats were placed in new cages until the 
next infection. Within the intermediate host, MF will develop and molt into infective L3 
larvae around 8-9dpi. Several mites were frequently analysed for L3 larvae count in order to 
maintain an estimation of the parasitemia [181, 183]. 
2.5 Infection with L. sigmodontis 
Experimental animals were infected in different ways; natural, subcutaneous, intradermal or 
intravenous. Nat. infection was performed via mites that were fed on microfilaremic cotton 
rats 10-12 days ago. Those mites were allowed to feed over night on 8-week-old mice, 
thereby transmitting infective L3 larvae to the mice. Therefore, mice were placed into the 
plastic basin, ground covered with mite-containing bedding. 
To ensure comparability, all animals were exposed to the same population of mites. During 
the blood meal of the intermediate host, infective L3 larvae are transmitted into the skin of the 
mice. Fed mites returned to the fine litter, covering the bottom basin. The following day, the 
bedding was removed and discarded. Afterwards, infected mice were placed for 24h above 
soap water to further remove mites that fall into the water. The next day, mice were placed in 
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new cages, containing fresh bedding, food and water. To achieve further mites removal, cage 
bedding was replaced on a daily basis for five days. On the sixth day post infection mice were 
relocated to a different facility, part of the IMMIP animal facilities and remained there until 
the day of necropsy. 
For i.d., s.c. and i.v. injection of infectious L3 L. sigmodontis larvae mites were dissected 
under the binocular microscope. Vital L3 larvae were isolated and collected. During s.c. 
injections, 40 L3 larvae in 100µl PBS media (PAA Laboratories GmbH, Pasching, Austria) 
were injected into the neck fold of the mice. Corresponding control mice were injected under 
the same conditions. 
Two days prior to i.d. injections, the upper hind leg region of mice was shaved using 
commercially available depilatory crème (Veet). For i.d. injections 10 L3 larvae in 100µl PBS 
or 30µg LsAg were injected. Control mice were injected with 100µl PBS  
For i.v. injections 40 L3 larvae in 100µl PBS were injected into the caudal vein of the mice. 
Same conditions were performed for corresponding control mice. During i.d., s.c. and i.v. 
injections the applied PBS was pre-warmed. 
2.6 LsAg preparation 
L. sigmodontis adult worms were isolated under sterile conditions from the thoracic cavities 
of infected mongolian gerbils. Thereupon, worms were collected in a petri dish and afterwards 
mechanically minced into a homogenized solution on ice using endotoxin-free PBS. The 
supernatant was taken and protein quantification was performed by Bradford assay (PAA, 
Pasching, Austria). LsAg aliquots were stored at -80°C.  
2.7 Determination of worm burden 
The thoracic cavity of euthanized mice were analysed to determine differences in the worm 
burden between IL-4R-/-, dblGATA, IL-5-/-, IL-4R-/-/IL-5-/-, S100A8/A9-/-, AhR-/- and 
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corresponding BALB/c and C57BL/6 control mice. Therefore, 10ml of pleural lavage was 
filtered using sterile 40µm gaze filter in order to isolate the worms. Afterwards the gaze filter 
was placed in a petri dish. Furthermore, the peritoneal cavity was checked for additional 
remaining worms. Adult male and female worms were counted and morphologically 
distinguished. 
2.8 Determination of microfilariae load 
L. sigmodontis-infected mice were periodically (starting from 50dpi) examined for MF load in 
the peripheral blood (50µl) taken from the vena facialis and resuspended in 1ml of red blood 
lysis buffer (10x RBC lysis buffer, eBioscience, San Diego, USA) at room temperature (RT). 
The blood was centrifuged at 400g for 5min at RT (Eppendorf Centrifuge 5810R). 
Afterwards, the supernatant was discarded and the pellet resuspended. MF load was then 
evaluated by the use of a light microscope, utilizing 10 x magnification. 
2.9 Analysis of female worm embryogenesis 
Embryonic stages (egg, morula, pretzel, stretched MF) were determined and enumerated from 
two female worms per animal (total of 10 worms per group). Worms were isolated from WT, 
IL-4R-/-, dblGATA, IL-5-/-, IL-4R-/-/IL-5-/- mice at 71 days post L. sigmodontis infection. 
Worms were individually homogenized by using a mortar in 80µl PBS and 20µl Hinkelmann 
solution (0.5% eosin Y, 0.5% phenol, 0.185% formaldehyde in destilled water). Embryonic 
stages in 10µl were determined and counted under a light microscrope (10 x magnification). 
2.10 Plasma isolation 
Before euthanasia of the mice blood was taken via the vena facialis using lancets (Goldenrod, 
Fisher Scientific, USA) and was directly transferred into EDTA tubes. Afterwards the isolated 
blood was centrifuged at 6000g/min at RT. Plasma was thereafter taken and stored at -20°C 
for further analysis.  
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2.11 Isolation of thoracic cavity cells 
Experimental animals were euthanized per inhalation of an overdose of Isoflurane, disinfected 
with 70% ethanol and fixed dorsally on a surgical board. Subsequently, the thoracic cavity 
was dissected by conducting a gentle incision starting at the abdomen up to the thorax. The 
skin was fixed marginally with pins. Within the exposed diaphragm, a small cut was 
performed. Afterwards the thoracic cavity was flushed utilizing a sterile Pasteur pipette with 
media (RPMI 1640, Gibco, Thermo Fisher Scientific Inc., Carlsbad, CA, USA) or PBS to isolate 
cells. Each flushing step was performed with a volume of 1ml and filtered through gauze to 
isolate the worms in case of L. sigmodontis-infected mice. The first ml was transferred into an 
Eppendorf tube and centrifuged for 5min at 400g at RT. The supernatant was kept in a 
deepwell plate and stored at -20°C for further cytokine/chemokine analysis. The pellet was 
combined with the volume of the ensuing flushing steps, in total 9ml and added to a 15ml 
falcon placed on ice for FACS analysis. 
2.12 Isolation of bronchoalveolar cells 
The trachea was surgically exposed and a small incision was performed at the cervico-
thoracic junction and a venous catheter (Vasofix Braunüle- B Braun, Germany) was inserted, 
followed by several washing steps of the bronchoalveolar space with 10ml of cold PBS. The 
first ml was collected in an Eppendorf tube and centrifuged at 400g for 5min at 4°C. The 
supernatant was added into a deepwell plate and stored at -20°C for further 
cytokine/chemokine and enzyme analysis. The pellet was pooled with the volume of the 
ensuing flushing steps (9ml) and added to a 15ml falcon placed on ice for FACS analysis. 
Afterwards, the cells were centrifuged at 400g for 5min at 4°C. At last, cell numbers were 
determined by Casy® Cell Counter (Hoffmann-La Roche Ltd, AG, Basel, Switzerland) and 
adjusted for further FACS analysis or cell culture stimulation experiments. 
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2.13 Isolation of splenocytes 
The spleen of dissected mice were removed surgically and added to a 15ml Falcon filled with 
5ml of media (RPMI 1640) or PBS and kept on ice. Afterwards, each spleen was grinded and 
pressed through a 70µm cell strainer (Miltenyi, Bergisch Gladbach, Germany) by utilizing a 
10ml syringe plunger. The flow-through was collected in a 15ml Falcon tube. Strainer and 
petri dish were flushed several times with RPMI medium to ensure higher isolation of cells. 
Next, cells were washed and centrifuged at 400g for 10min at 4°C. The supernatant was 
discarded and the pellet was resuspended with 1ml of red blood cell lysis buffer (Thermo 
Fisher, San Diego, USA) for 5min at RT. Lysis was stopped by adding further 9ml of RPMI 
medium and washed again by centrifugation at 400g for 10min and 4°C. The supernatant was 
discarded and the pellet was resuspended in 10ml of RPMI cell culture medium. Cell numbers 
were determined by Casy® Cell Counter and adjusted for further FACS analysis or cell 
culture stimulation experiments. 
2.14 Stromal vascular fraction (SVF) and liver cell isolation 
Mice were anaesthetized (Rompun - Bayer, Ketamin – WDT, Germany) and fixed on a 
surgical board for tissue and organ removal. The skin and peritoneum were gently dissected 
and mice were intracardially perfused for 5min with 1x PBS to remove non-adhering, non-
infiltrating erythrocytes and blood-lymphocytes. Subsequently, visceral adipose tissue (VAT) 
from the intraabdomen and liver was removed and collected in DMEM-low glucose medium 
(Gibco, life technologies, USA) containing 1g/L D-glucose (Sigma Aldrich, Steinheim, 
Germany), 4mM L-Glutamine, 25mM HEPES, 1g/ml BSA and 1% penicillin-streptomycin 
(all PAA Laboratories GmbH, Pasching, Austria). Resected tissue was minced by scissors and 
transferred to 15ml falcons, containing 4ml medium of 1.5mg/ml Collagenase-P (Roche, 
Mannheim, Germany).  
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Thereupon tissue suspension was incubated at 37°C for 30min with continuous shaking. 
During half of the incubation period samples were mixed thoroughly by hand. After a 30min 
incubation step samples were washed with MACS buffer (Miltenyi, Bergisch Gladbach, 
Germany) and centrifuged at 400g for 5min at RT. Supernatant was discarded and red blood 
lysis was performed (Thermo Fisher Scientific, San Diego, USA) by adding 1ml lysis buffer 
for 5min at RT. Lysis reaction was stopped by adding 9ml of MACS buffer. Samples were 
filtered through a 100µm filter and then centrifuged at 400g for 5min at RT. Afterwards, the 
supernatant was discarded and cell numbers were determined by Casy® Cell Counter and 
adjusted for further FACS analysis or cell culture stimulation experiments.  
2.15 Freezing of cells 
FixPerm Substrat® was diluted (1:3) with FixPerm Diluent® (Thermo Fisher Scientific, San 
Diego, USA). Cells were fixed in 300µl FixPerm® buffer overnight at 4°C. The next day, a 
washing step was performed by adding 1ml of PBS and centrifuged at 400g for 10min at 4°C. 
The supernatant was removed and the cell pellet was resuspended in 1ml PBS/10% DMSO 
(Sigma-Aldrich, Steinheim, Germany). Cells were frozen and stored at -20°C.  
2.16 Neutrophil Purification - Percol 
Mice were euthanized per inhalation of an overdose of Isoflurane. Afterwards, the femurs of 
S100A8/A9-/- and corresponding WT controls were removed surgically and the remaining 
tissue was detached. The condyles of the bones were cut and subsequently the bone marrow 
was flushed with 5ml of cold sterile PBS by utilizing a 10ml syringe and a 27G needle. The 
flow-through was filtered immediately and collected in a 15ml falcon tube. Next, a 
centrifugation step was performed at 400g for 5min at 4°C and the supernatant was removed. 
Red blood cell lysis was performed by adding 1ml RBC lysis buffer for 5min at RT. Lysis 
was stopped by adding an additional 9ml of cold sterile PBS. Afterwards, the cells were 
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washed and centrifuged again at 400g for 10min at 4°C. The supernatant was discarded and 
the cell pellet was resuspended in 3ml of PBS. Neutrophil purification was conducted by a 3-
layer Percoll gradient method. A stock solution of 100% Percoll (GE Healthcare Life 
Sciences, Munich, Germany) was prepared by adding 9 volumes of pure Percoll and one 
volume of 10x PBS. Further, Percoll solutions at 72%, 64% and 52% were prepared by 
diluting 100% Percoll solution. 
RPMI media was used for better visible separation of the different layers. Each layer consists 
of 3ml and was added carefully into a 15ml falcon tube in a percentage dependent manner 1) 
72%  2) 64%  3) 52%  4) cells. Afterwards, the tube was centrifuged for 30min at 
1500g at RT without brake. Neutrophils are found at the interface between the 72% and 64% 
layers and were recovered by a soft Pasteur pipette. Next, cells were washed with PBS and 
centrifuged at 400g for 5min at RT. After the centrifugation step, the supernatant was 
removed and cells were resuspended in 1ml of PBS. Cell numbers were determined by Casy® 
Cell Counter and adjusted for further FACS analysis or cell culture stimulation experiments. 
2.17 Bronchoalveolar cell and splenocytes stimulation 
Splenocytes were isolated as previously described under 2.13 and cultured in 1ml of media 
(RPMI 1640) containing 10% FCS, 1% L-Glutamine 100U / mL Penicillin-Streptomycin 
under different conditions for 72h at 37°C (5% CO2, 80% humidity). Each condition consisted 
of 2x106 cells. Cells were stimulated with either Concanavalin A (ConA) (2.5µg/ml) (Sigma-
Aldrich, St. Louis, MO, USA) or LsAg (25µg/ml). Unstimulated cells were used as control. 
After 72h of incubation the supernatant was recovered and frozen at -20°C for further 
cytokine analysis. 
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2.18 Conditioned media culture of CD4+ and CD8+ T cells 
Splenocytes were isolated as described under 2.13 splenic CD4+ and CD8+ T cells were 
separated by magnetic MACS beads according to the manufacturer´s protocol (Milteny 
Biotec, Bergisch Gladbach, Germany). CD4+ and CD8+ T cells from obese mice were 
cultured for 4h in adipocyte conditioned media from LsAg and PBS-administrated mice with 
a cocktail containing PMA (50ng/ml), ionomycin (1µg/ml) (Sigma-Aldrich, St. Louis, MO, 
USA), Golgi Plug and Golgi Stop (0.66µg/ml) (BD Bioscience, Franklin Lakes, USA). 
Adipocyte conditioned media was assessed by daily i.p. (in total 4 weeks) injections of 2µg 
LsAg and PBS as corresponding controls in mice fed for 10-12 weeks with normal food diet 
(NFD) or either HFD. In summary, 100mg of adipose tissue was isolated and digested with 
collagenase. After three washing steps, old media was replaced with fresh media. Ddipocytes 
from NFD or HFD were cultured with purified splenic CD4+ or CD8+ T cells as described 
previously.  
2.19 Neutrophil cell culture conditions  
Bone marrow-derived neutrophils were isolated as previously described under 2.16. Each 
condition consisted of 1x105 neutrophils and was performed in triplicates. Neutrophils were 
cultured in 200µl of RPMI 1640 media containing 10% FCS, 1% L-Glutamine, 100U/mL 
Penicillin-Streptomycin for 2h and 6h at 37°C (5% CO2, 80% humidity)
 . Cells were 
stimulated with LPS Ultrapure (100ng/ml) (InvivoGen, San Diego, USA) and crude worm L. 
sigmodontis extract LsAg (50µg/ml). Unstimulated cells were used as control. After 7h of 
culture the supernatant was recovered and frozen at -20°C for further cytokine, chemokine 
and enzyme analysis. Cells were taken for FACS analysis. 
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2.20 Neutrophil depletion within the lung 
Mice were treated intranasally with 250µg/ml anti-Ly6G antibody (Clone 1A8) (BioXCell, 
West Lebanon, USA) to deplete neutrophils within the lung. Depletion was performed 18h 
prior to infection with L. sigmodontis and repeated every other day until 5dpi. Corresponding 
control mice were treated with an IgG2a isotype antibody (Clone C1.18.4) (BioXCell, West 
Lebanon, USA). Neutrophil depletion within the bronchoalveolar lavage was confirmed via 
flow cytometry. 
2.21 Enzyme-linked immunosorbent assay (ELISA) 
Determination of cytokine, chemokine and enzyme concentrations in pleural, bronchoalveolar 
lavage and cell culture supernatants was performed utilizing the Sandwich-ELISA method. 
ELISAs were performed in duplicates according to the manufacturer’s kit protocols (Thermo 
Fisher Scientific: IL-4, IL-5, IL-6, IL-13, IFN-γ, TNF, IL-1β) (Thermo Fisher Scientific, 
Waltham, USA) (R&D systems: CXCL-1, CXCL-2, CXCL-5, elastase, adiponectin) (R&D, 
Minneapolis, USA). ELISA plates (Greiner Bio-One, Solingen, Germany) were coated with 
primary antibody (capture), diluted in either coating buffer (10x coating buffer (1:10 dilution 
dest. water) (Thermo Fisher Scientific, Waltham, USA) or PBS (R&D) overnight at 4°C. The 
following day, plates were washed thrice with washing buffer (PBS/0,05% Tween20( 
Sigma-Aldrich, St. Louis, MO, USA)) and subsequently blocked with either 1x Assay diluent 
(Thermo Fisher Scientific, Waltham, USA) or PBS/1% BSA (R&D) for 2h at RT. Afterwards, 
plates were washed thrice, corresponding serial dilutions of standards and samples were added 
in duplicates overnight at 4°C. 1x Assay diluent or PBS/1% BSA was used as blank controls. 
On the third day, plates were washed for five times and the second antibody (detection) was 
added for a further duration of 1h at RT. After five washing steps the enzyme horseradish 
peroxidise (R&D, Minneapolis, USA) or avidin peroxidase (Thermo Fisher Scientific, 
Waltham, USA) was added for 1h at RT.  
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Plates were washed again for five times. Subsequently tetramethylene benzidine (TMB) 
(Thermofisher, Inc., San Diego, CA, USA) was added until the color change occurred. Further 
change in color was stopped by adding 25 µl of 1M H2SO4 (Merck, Darmstadt, Germany). 
Determination of the concentration was evaluated by the optical density (OD) at 450nm and 
650nm was used as reference using SpectraMAX 340 Pc plate reader (Molecular Devices, 
Ismaning, Germany). 
2.22 Flow cytometry - Fluorescence activated cell scan (FACS)  
To analyze cellular composition, cell activation and intracellular cytokines within the thoracic 
cavity, spleen, skin and lung, the single cell suspensions were stained for cell surface markers 
and analyzed via flow cytometry by subdividing a cell population into sub-populations based 
on size (Forward Scatter (FSC)), granularity (Sideward Scatter (SSC)) and fluorescent 
labeling. Prior to the analysis, isolated cells were washed and blocked in PBS containing 1% 
BSA and rat Ig (1μg/ml, Sigma-Aldrich, St. Louis, MO, USA) for 1h. Cells were then 
centrifuged at 400g for 5min at 4°C and stained by fluorescent-marked monoclonal antibodies 
in FACS tubes. Compensation was performed via BD compensation beads. Gate setting for 
specific cell populations was based on the Fluorescence minus one (FMOs) approach, which 
lacks one of the utilized antibodies.  
For intracellular staining of RELMα or intracellular cytokines, isolated cells were incubated 
in 300µl fixation and permeabilization buffer overnight at 4°C. Next day, cells were washed 
and centrifuged at 400g for 5min at 4°C. Afterwards, fixed cells were incubated in 300µl 
permeabilization buffer (Thermo Fisher Scientific, San Diego, USA) for 20min at RT. Next, 
cells were washed during a centrifugation step and subsequently blocked in PBS/1% BSA 
containing rat Ig (1μg/ml) for 1h at 4°C. After two further washing steps in permeabilization 
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buffer for 10min at 400g, cells were stained or prepared for cell culture simulation (LPS, 
ConA, LsAg, PMA/ Ionomycin with Golgi Plug & Golgi Stop). 
For RELMα staining, fixed and permeabilized cells were stained with rabbit-anti-mouse 
RELMα (Peprotech, Rocky Hill, NJ, USA) for 1h at 4°C in the dark. Cells were then washed 
in permeabilization buffer and centrifuged at 400g for 5min at 4°C. Subsequently, cells were 
stained with the corresponding secondary antibody (goat anti-rabbit Alexa488, Invitrogen, 
Carlsbad, CA, USA) for 30min at 4°C in the dark. Measurement and analysis was acquired 
using the BD Canto (BD Biosciences, Heidelberg, Germany) and BD FACSDiva software. 
2.23 Glucose tolerance test 
Six hours before performing the glucose tolerance test (GTT), C57BL/6 mice were fasted. 
Fasting blood glucose levels were measured from the tail vein using a blood glucose meter 
(Accu-Check Advantage, Roche Diagnostics GmbH, Mannheim, Germany). During glucose 
challenge mice were injected i.p. with a dose of 2g glucose monohydrate (Merck, Darmstadt, 
Germany) solution per kg body weight. Periodically at 15, 30, 60, 90, and 120min post 
glucose injection, blood was taken by the tail vein and glucose concentrations were 
determined. 
2.24 Insulin tolerance test  
Four hours before performing the insulin tolerance test (ITT), C57BL/6 mice were fasted by 
removing NFD and HFD. After 4h, fasting blood glucose levels were measured from the tail 
vein using a blood glucose meter (Accu-Check Advantage, Roche Diagnostics GmbH, 
Mannheim, Germany). During insulin challenge, mice were injected i.p. with a dose of 
0.001U/g body weight of insulin. At 15, 30, 60, 90, and 120min post insulin injection, blood 
was taken from the tail vein and glucose concentrations were determined. 
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2.25 Lung histology and immunhistology  
S100A8/A9-/- and C57BL/6 WT naive and infected mice (nat., s.c., i.v. infection) were 
sacrificed at 12dpi. The bronchoalveolar space was flushed several times as described 
previously. Next, the lung was fixed in 4% formalin overnight. The following day, the 
fixative was renewed for another 24h. Afterwards, lungs were placed in 70% alcohol for 2-7 
days before paraffin embedding. Five-micron-thick serial sections were prepared. Each lung 
was stained with a haematoxylin-eosin (H&E) solution. The peri-vascular space (PVS) was 
analysed by utilizing a Masson’s trichrome staining (Sigma-Aldrich, St. Louis, MO, USA) to 
visualize and pictorially accentuate collagen fibers according to the manufacturer protocols. 
Immunostained serrations were washed in PBS and subsequently tissue peroxidase was 
blocked by utilizing a dual endogenous enzyme block (Dako, Les Ulis, France) and 
biotin/avidin by a biotin blocking kit (Vector, Malakoff, France). Neutrophils were first 
stained in a 1/200 dilution with a primary antibody against Ly-6G (rat monoclonal AB, clone 
NIMP-R14, Hycult Biotech, Uden, Netherlands) dissolved in blocking serum (Vectastain kit, 
Vector, Malakoff, France). Antigen recovery was performed by using an antigen unmasking 
solution (Vector, Malakoff, France) at pH 6. Afterwards, S100A9 was stained with the 
primary antibody against S100A9 (rat monoclonal Ab, clone MU14-2A5, Hycult Biotech 
1:200) in blocking serum (Vectastain kit, Vector, Malakoff, France). A proteinase K solution 
(0.004%), diluted in a 1:1 glycerol-modified Tris Buffer (EDTA 3.7%, Triton X-100 0.5%, 
pH 8), was used for antigen retrieval for 10min at 37°C. S100A9 detection was conducted by 
the Vectastain Elite ABC kit (Vector, Malakoff, France). Disclosure was performed with a 
high sensitivity AEC substrate (Dako, Les Ulis, France), which was subsequently 
counterstained with a Mayer’s hematoxylin solution (Merck, Semoy, France). 
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2.26 Vascular permeability assay 
In vivo vascular permeability was assessed via the intracutaneous injection of 10µg LsAg or 
of PBS as corresponding control in the ears of mice. After 3min mice were injected i.v. with 
30mg/kg body weight of Evans Blue (Sigma-Aldrich, St. Louis, MO, USA) in 200µl of NaCl 
0.9%. After a subsequent incubation time of 10min, mice were euthanized and ears were 
removed and transferred into 500µl of >99% formamide (Sigma-Aldrich, St. Louis, MO, 
USA) and incubated at 56°C for 24h. Evans Blue leakage was quantified by determing optical 
density at 620nm (Molecular Devices, Ismaning, Germany). 
2.27 L. sigmodontis L3 larvae in vitro assay 
10 L3 larvae were cultured with 1x105 WT and S100A8/A9-/- neutrophils in triplicates in 
enriched media (RPMI 1640 media + 10% FCS, 1% L-Glutamine, 100U/mL Penicillin-
Streptomycin) for 48h at 37°C (5% CO2 ,90% humidity). Motility was assessed daily by a five 
point scoring system; Score 4: vigorous, fidgeting movements. Score 3: slightly impaired 
vigorous movements. Score 2: impaired motility/slow movements. Score 1: mostly 
immobile/single movements. Score 0: fully immobile within 20s observation period. 
 
2.28 Statistics 
Data were analyzed for statistical significance using GraphPad Prism 5.03 software 
(GraphPad Software, La Jolla, California, USA). Differences between two unpaired groups 
were tested for statistical significance with the Mann-Whitney-U-test. Normal distribution of 
the data was tested with D’agostino test. Parametrically distributed data were analyzed by 
one-way ANOVA followed by Dunnett’s test, whereas non-parametrically distributed data 
were analyzed by Kruskal-Wallis test followed by Dunn’s posthoc test. P-values of <0.05 
were considered statistically significant. 
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3. Results 
3.1 Role of IL-4R, IL-5 and eosinophils on L. sigmodontis infection 
3.1.1 IL-4R, IL-5 and eosinophils are essential for control of the occurrence of 
microfilaremia, whereas IL-5 and eosinophils impair adult worm survival, 
embryogenesis and maintenance of microfilaremia 
Previous studies confirmed that type 2 immune response, involving eosinophils, IL-5 and IL-
4, exhibit protective immune responses against L. sigmodontis. In the present project the 
impact of eosinophils, IL-5, and the IL-4R was directly compared on the outcome of L. 
sigmodontis infection during the peak of microfilaremia in WT animals (71dpi) and a late 
phase of infection (119dpi) after IL-4R-/-/IL-5-/- mice showed a first decline in microfilaremia 
and most WT animals cleared the infection. Therefore, microfilarial burden and frequency of 
animals developing microfilaremia were analyzed over time. During necroscopies at 71 and 
119dpi total adult worm numbers and worm lengths were determined. Furthermore, analysis 
of the cytokine production from thoracic cavity lavage, the site of adult worm residence, 
embryogenesis and major immune cell types were performed within the thoracic cavity and 
spleen. MF counts revealed increased numbers of peripheral MF throughout the infection in 
all tested immunocompromised mice (IL-4R-/-, IL-5-/-, IL-4R-/-/IL-5-/- and dblGATA BALB/c 
mice) compared to WT controls (Fig. 3A). Furthermore, the onset of microfilaremia into the 
peripheral blood in all immune-deficient mouse strains was observed much earlier (56dpi) 
compared to WT controls (64dpi). IL-4R-/-/IL-5-/- mice exhibited the highest MF counts 
during the whole time period. At 56dpi, 90% of IL-4R-/-and 95% of IL-4R-/-/IL-5-/- mice were 
positive for MF, whereas microfilaremia occurred in 39% of IL-5-/- and 66% in dblGATA 
mice in comparison to merely 10% of the WT controls (Fig. 3B). The peak of microfilaremia 
was observed in WT (~6 MF/50µl blood) and dblGATA mice at 78dpi (~746 MF/50µl 
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blood), in IL-4R-/- (~294 MF/50µl blood) at 70dpi, and in IL-5-/- (~639 MF/50µl blood) and 
IL-4R-/-/IL-5-/- at 97dpi (~4600 MF/50µl blood) (Fig. 3A). 
 Microfilaremia persisted in IL-4R-/-/IL-5-/-, dblGATA, and IL-5-/- mice for >120dpi, while 
microfilaremia declined in IL-4R-/- and WT controls following 78dpi (Fig. 3A). All immune-
deficient mice exhibited a substantially higher frequency of MF positive animals (dblGATA, 
IL-4R-/-/IL-5-/- mice: 100%, IL-5-/- mice: 58.5%, IL-4R-/- mice: 100%) compared to WT 
controls (30%; Fig. 3B). 
Adult worm counts were determined and showed an increase in all analysed immune-deficient 
mouse strains (dblGATA, IL-5-/-, IL-4R-/-/IL-5-/-) except for IL-4R-/- mice compared to WT 
controls. For IL-5-/- and dblGATA mice at 71 and 119dpi, the differences were statistically 
significant in comparison to WT mice (Fig. 3C, D). At 119dpi an increased number of 
granuloma was observed in the IL-4R-/-/IL-5-/- mice, which hampered the exact worm counts 
and may explain the lower worm numbers in comparison to the dblGATA and IL-5-/- mice.  
To elucidate, whether the increased MF counts in IL-4R-/-/IL-5-/-, dblGATA and IL-5-/- mice 
are due to an enhanced embryogenesis of female adult worms in comparison to WT controls, 
embryograms were performed. Embryograms from 71dpi demonstrate that female adult 
worms from IL-4R-/-/IL-5-/- animals had significantly higher numbers of all embryonal stages 
(eggs, morulae, pretzel, and stretched MF) compared to WT animals and of the later 
embryonal stages (pretzel and stretched MF) in comparison to IL-5-/- mice. In contrast, female 
adult worms from dblGATA and IL-5-/- mice exhibited significant increased numbers of the 
early embryonal stages (eggs: p<0.01/p<0.05; morulae: p>0.05), but no significantly 
increased number of stretched MF. These data indicate that the highest MF count in IL-4R-/-
/IL-5-/- animals is in part due to an enhanced embryogenesis (Fig. 3E).  
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Worm lengths of adult male and female worms were significantly longer in all tested immune 
compromised mouse strains compared to worms from WT controls at 71dpi (mean female 
worm length: WT 4.82cm, IL-4R-/- 5.54cm, dblGATA 5.62cm, IL-5-/- 5.30cm, IL-4R-/-/IL-5-/- 
6.51cm; mean male worm length: WT 1.54cm, IL-4R-/- 1.97cm, dblGATA 1.62cm, IL-5-/- 
1.68cm, IL-4R-/-/IL-5-/- 2.11cm ; Fig. 3F, G). Filariae lengths of adult male and female worms 
at 119dpi did not show any statistical differences between all utilized mouse strains (Fig. 3H, 
I). Besides, the ratio of male and female adult worms on 71 and 119dpi was not altered in any 
of the mouse strains tested (data not shown).  
These results indicate that the release and maintenance of microfilaremia is efficiently 
regulated by IL-4R and IL-5/eosinophils. IL-5/eosinophils affect adult worm survival and 
thereby the maintenance of microfilaremia. This effect on microfilaremia was further 
promoted by the combined deficiency of IL-4R and IL-5. 
 
 
 
 
 
 
 43 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 80 100 120
1
10
100
1000
10000
WT
IL-4R
-/-
dblGATA
IL-5
-/-
IL-4R
-/-
/IL-5
-/-
*** *** *** *** *** *** *** *** **
* WT vs IL-4R
-/-
/IL-5
-/-
+++ +++ ++ +++ +++ +++ +++ +++
+
dblGATA vs IL-4R
-/-
/IL-5
-/-
days post infection
M
ic
ro
fi
la
ri
a
e
 /
 5
0
µ
l 
b
lo
o
d
 (
+
1
)
60 80 100 120
0
20
40
60
80
100
days post infection
M
f 
p
o
s
. 
a
n
im
a
ls
 (
%
)
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0
25
50
100
200
300
***
*
*
n
u
m
b
e
r 
o
f 
w
o
rm
s
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0
25
50
100
200
300
*
**
**
**
n
u
m
b
e
r 
o
f 
w
o
rm
s
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0
5
10
15 ***
**
***
***
le
n
g
th
 (
c
m
)
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0
1
2
3
4
***
***
***
***
le
n
g
th
 (
c
m
)
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0
5
10
15
le
n
g
th
 (
c
m
)
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0
1
2
3
4
le
n
g
th
 (
c
m
)
Microfilariae load
Mf positive
Adult worm burden (71dpi) Adult worm burden (119dpi)
Female length (71dpi) Male length (71dpi)
Female length (119dpi) Male length (119dpi)
A B
C D
F G
H I
E
Embryogenesis (71dpi)
eg
g
m
or
ul
a
pr
et
ze
l
m
f
eg
g
m
or
ul
a
pr
et
ze
l
m
f
eg
g
m
or
ul
a
pr
et
ze
l
m
f
eg
g
m
or
ul
a
pr
et
ze
l
m
f
1
10
100
1000
10000
100000
WT dblGATA IL-5
-/- IL-4R-/-/IL-5-/-
** * *** *** *** *
4/10 MF+ 7/10 MF+ 3/10 MF+ 8/10 MF+
+++ +++
N
u
m
b
e
r
* comparison to WT
+ IL-5-/- vs. IL-4R-/-/IL-5-/-
 44 
 
 
 
 
 
 
 
 
 
3.1.2 Negative association between thoracic cavity eosinophils and adult worm survival 
as well as AAMs with microfilaremia  
Helminth infections are associated with increases of several cell frequencies such as 
eosinophils during chronic infections leading to eosinophilia or an increased frequency of 
AAMs. Therefore, potential correlations between different frequencies of immune cell 
populations with the pronounced number of MF and adult worms in immune-deficient mice 
were determined. Therefore, thoracic cavity and spleen cells of WT, IL-4R-/-, dblGATA, IL-5-
/-, and IL-4R-/-/IL-5-/- mice on 71 and 119 days post L. sigmodontis infection were assessed 
and analysed by flow cytometry. Total numbers of thoracic cavity cells were lower in 
dblGATA, IL-5-/- and IL-4R-/-/IL-5-/- mice compared to WT controls at 71dpi, reaching 
statistical significance for IL-5-/- and IL-4R-/-/IL-5-/- mice (Fig. 4A). Thoracic cavity cell 
counts at 119dpi were comparable and did not show any statistical differences between WT 
and immune-compromised mice (Fig. 4B). The absence of IL-4R at 71 and 119dpi resulted in 
Fig. 3: IL-4R and IL-5/eosinophils control microfilaremia, whereas IL-5 and eosinophils impair adult 
worm survival and maintenance of microfilaremia. (A) Microfilariae count per 50μl of peripheral blood 
throughout L. sigmodontis infection and (B) frequency of wildtype (WT) controls, IL-4R-/-, dblGATA, IL-5-/-, 
IL-4R-/-/IL-5-/- mice that develop microfilaremia. Adult worm burden (C, D), embryogenesis of female adult 
worms staged as eggs, morulae, pretzel and stretched microfilariae at 71 days post infection (dpi) with 
numbers of female worms containing stretched microfilariae within their uteri indicated above the different 
mouse strains (E), and female (F, H) and male worm length (G, I) at 71 (C, F, G) and 119 (D, H, I) dpi. 
Results are shown as means ± SEM (A, B, E), medians (C, D), and box & whisker plots with minimum and 
maximum (F-I). Data were analyzed using two-way ANOVA followed by Bonferroni’s post-test (A), one-
way ANOVA followed by the Dunnett’s test (F) and Kruskal-Wallis test followed by the Dunn’s multiple 
comparison test (C-E, G-I).*p<0.05, **p<0.01, ***p<0.001. Data shown in (A-C) are pooled from two 
independent experiments at 71dpi with a total of 10-16 mice per group. Data shown in (D, F-I) are from one 
experiment with 6-10 mice per group and data shown in (E) from a single experiment with 5 mice per group 
and analysis of 2 female worms per mouse. 
Fig. 1. IL-4R and IL-5/e sinophils control microfilaremi , whereas IL-5 and eosinophils impair ad lt worm survival and 
maintenance of microfilaremia. (A) Microfilariae count per 50 μl of peripheral blood throughout L. sigmodontis infection and (B) 
frequency of wildtype (WT) controls, IL-4R-/-, dblGATA, IL-5-/-, IL-4R-/-/IL-5-/- mice that developed microfilaremia. Adult worm burden 
(C, D) and female (E, G) and male worm length (F, H) at 71 (C,E,F) and 119 (D,G,H) days post infection (dpi). Results are shown as 
means ± SEM (A, B), medians (C, D), and box & whisker plots with minimum and maximum. Differences were analyzed for statistical 
significance using the Kruskal-Wallis test followed by the Dunn’s multiple comparison test. *p<0.05, **p<0.01, ***p<0.001. 
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reduced absolute numbers of macrophages (Fig. 4C, D) and a lack of AAMs (Fig. 4E, F) 
within the thoracic cavity of IL-4R-/- and IL-4R-/-/IL-5-/- mice. As expected total numbers of 
eosinophils in IL-5 and dblGATA deficient mice were barely present (Fig. 4G, H).  
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Absolute numbers of thoracic cavity CD4+ T cells, CD8+ T cells and neutrophils were 
determined on 71 and 119dpi (Fig. 5). At 71dpi, absolute CD4+ T cell numbers were 
increased in IL-5-/- mice (Fig. 5A) and neutrophil numbers were significantly increased in IL-
4R-/-/IL-5-/- mice in comparison to the corresponding control group (Fig. 5E). Those 
differences in CD4+ T cell and neutrophil numbers were not observed anymore at 119dpi 
(Fig. 5B, F). Absolute CD8+ T cell numbers did not show any statistical differences between 
all tested mouse strains at 71 and 119dpi (Fig. 5C, D). 
 
 
 
 
Fig. 4: Thoracic cavity cells of L. sigmodontis-infected IL-5-/-, dblGATA and IL-4R-/-/IL-5-/- mice lack 
eosinophils and IL-4R-/- and IL-4R-/-/IL-5-/- mice lack alternatively activated macrophages. Total number 
of thoracic cavity cells in IL-4R-/-, dblGATA, IL-5-/-, IL-4R-/-/IL-5-/- mice and wildtype (WT) controls 71 (A) 
and 119 days (B) post L. sigmodontis infection. Total thoracic cavity macrophage numbers (C, D), RELMα 
positive alternatively activated macrophage (AAM, E, F) and eosinophil numbers (G, H) at 71 and 119 days 
post L. sigmodontis infection (A-H), as well as expression of CD54 (I) and CD69 on eosinophils (J) at 71 
days post L. sigmodontis infection and naïve WT controls (G-J). Results are shown as medians. Data were 
analyzed using one-way ANOVA followed by the Dunnett’s test (C, G, H) and Kruskal-Wallis followed by 
the Dunn’s multiple comparison test (A, B, D, E, F, I, J).*p<0.05, **p<0.01, ***p<0.001. Data shown in (A, 
C, E, G) are pooled from two independent experiments at 71dpi with 10-16 mice per group. Remaining 
figures (B, D, F, H) are from one experiment at 119dpi with 6-10 mice per group. Figures (I, J) are 
representative of one independent experiment at 71dpi with 4-6 mice per group. 
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Fig. 5: Mice deficient for IL-5, dblGATA, IL-4R and IL-4R/IL-5 show no strong influence on CD4+ T 
cells, CD8+ T cells and neutrophil numbers within the thoracic cavity. Total thoracic cavity CD4+ T cell 
numbers (A, B), CD8+ T cell numbers (C, D) and neutrophil numbers (E, F) at 71 and 119 days post L. 
sigmodontis infection in IL-4R-/-, dblGATA, IL-5-/-, IL-4R-/-/IL-5-/- mice and wildtype (WT) controls. Results are 
shown as medians. Data were analyzed using one-way ANOVA followed by the Dunnett’s test (A, E) and 
Kruskal-Wallis followed by the Dunn’s multiple comparison test (B, C, D, F).*p<0.05. Data shown in (A, C, E) 
are pooled from two independent experiments at 71dpi with 10-16 mice per group. Remaining figures (B, D, F) 
are from one experiment at 119dpi with 6-10 mice per group.  
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Spearman correlation analysis revealed a strong negative correlation between thoracic cavity 
eosinophil numbers and adult worm counts at 71dpi (r= -0.61; p=0.0001; Fig. 6A), which was 
not present anymore at 119dpi (r= -0.07; p=0.61; Fig. 6B). Furthermore, thoracic cavity 
eosinophil numbers negatively correlated to the MF load at 71 (r= -0.46; p=0.005) and 119dpi 
(r= -0.24; p=0.13; Fig. 6C, D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6: Negative correlation of thoracic cavity eosinophil numbers and adult worm burden as well as MF 
counts. Correlation of the total thoracic cavity eosinophil numbers and adult worm burden (A, B) and 
peripheral blood MF counts (C, D) at 71 (A, C) and 119 days (B, D) post L. sigmodontis infection in IL-4R-/-, 
dblGATA, IL-5-/-, IL-4R-/-/IL-5-/- mice and wildtype controls. Spearman correlation. Data shown in (A, C) are 
pooled from two independent experiments at 71dpi with 10-16 mice per group. Remaining figures (B, D) are 
from one experiment at 119dpi with 6-10 mice per group. 
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Thoracic cavity AAM counts did not show any correlation with adult worm counts at 71dpi 
(r=0.08; p=0.57; Fig. 7A), but a positive correlation at 119dpi (r= 0.70; p=0.0001; Fig. 7B). 
Interestingly, AAM numbers correlated negatively with the MF load 71dpi (r= -0.34; p=0.02; 
Fig. 7C), but disappeared during the late phase (119dpi) of L. sigmodontis infection (r= 0.14; 
p=0.38; Fig. 7D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The aforementioned results support an essential role of thoracic cavity eosinophils for adult 
worm and MF elimination, whereas AAMs correlated with reduced MF counts. 
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Fig. 7: Contrasting correlation of thoracic cavity alternatively activated macrophage numbers and adult 
worm burden and MF counts. Correlation of the total thoracic cavity RELMα-positive macrophage numbers 
and adult worm burden (A, B) and peripheral blood MF counts (C, D) at 71 (A, C) and 119 days (B, D) post L. 
sigmodontis infection in IL-4R-/-, dblGATA, IL-5-/-, IL-4R-/-/IL-5-/- mice and wildtype controls. Spearman 
correlation. Data shown in (A, C) are pooled from two independent experiments at 71dpi with 10-16 mice per 
group. Remaining figures (B, D) are from one experiment at 119dpi with 6-10 mice per group. 
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3.1.3 Positive association of splenic neutrophils with adult worm and MF survival  
Splenocytes of all immune-deficient mouse strains and WT controls were assessed and 
immunological analysis was performed via flow cytometry. Absolute spleen cell counts were 
increased in the immune-compromised mice compared to WT controls at 71dpi, reaching 
statistical significance for IL-4R-/-/IL-5-/- mice (Fig. 8A). During the late phase of L. 
sigmodontis infection at 119dpi, spleen cell numbers of dblGATA mice were significantly 
increased compared to WT controls (Fig. 8B). Numbers of neutrophils were significantly 
increased in spleens of IL-5-/- and IL-4R-/-/IL-5-/- mice on 71dpi (Fig. 8C) and in IL-4R-/-/IL-5-
/- mice at 119dpi compared to WT controls (Fig. 8D). A strong positive correlation was 
observed for neutrophil counts in the spleen with MF load at 71 (r= 0.47; p=0.001; Fig. 8E) 
and 119dpi (r= 0.40; p=0.01; Fig. 8F) as well as adult worm burden at both time points 
(71dpi: r= 0.43; p=0.003; 119dpi: r= 0.45; p=0.002; Fig. 8G, H). 
 
 
 
 
 
 
 
 
 51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0.0
1.01008
2.01008
3.01008
4.01008
5.01008
**
T
o
ta
l 
c
e
ll
 n
u
m
b
e
r
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0.0
1.01008
2.01008
3.01008
4.01008
*
T
o
ta
l 
c
e
ll
 n
u
m
b
e
r
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0
5000
10000
15000
*
**
T
o
ta
l 
c
e
ll
 n
u
m
b
e
r
WT IL-4R
-/-
dblGATA IL-5
-/-
IL-4R
-/-
/IL-5
-/-
0
2000
4000
6000
8000
10000
**
***
T
o
ta
l 
c
e
ll
 n
u
m
b
e
r
0 2000 4000 6000 8000
0
5000
10000
15000
r= 0.4732
p=0.0014
MF
N
e
u
tr
o
p
h
il
s
 t
o
ta
l 
c
e
ll
 n
u
m
b
e
r
0 1000 2000 3000 4000
0
2000
4000
6000
8000
10000
r= 0,4008
p= 0,011
MF
N
e
u
tr
o
p
h
il
s
 t
o
ta
l 
c
e
ll
 n
u
m
b
e
r
0 100 200 300
0
5000
10000
15000
r= 0.4324
p=0.0038
Worm burden
N
e
u
tr
o
p
h
il
s
 t
o
ta
l 
c
e
ll
 n
u
m
b
e
r
0 50 100 150 200
0
2000
4000
6000
8000
10000
r= 0.4577
p=0.0026
Worm burden
N
e
u
tr
o
p
h
il
s
 t
o
ta
l 
c
e
ll
 n
u
m
b
e
r
Neutrophils (71dpi) Neutrophils (119dpi)
71dpi 119dpi
Splenocytes (71dpi) Splenocytes (119dpi)
71dpi 119dpi
A B
C D
E F
G H
 52 
 
 
 
 
 
 
 
Total numbers of CD4+ T cells, CD8+ T cells, neutrophils, macrophages and eosinophils 
were determined within the spleen on 71 and 119dpi (Fig. 9). A significant decrease of 
absolute CD4+ T cell numbers was observed for IL-4R-/- and IL-5-/- deficient mice at 71dpi 
(Fig. 9A), whereas CD4+ T cells were lower in dblGATA and IL-5-/- mice compared to WT 
controls at 119dpi (Fig. 9B). CD8+ T cell numbers were significantly decreased in IL-4R-/-, 
IL-5-/- and IL-4R-/-/IL-5-/- on 71dpi (Fig. 9C) and continued to decrease at 119dpi for IL-4R-/- 
and IL-4R-/-/IL-5-/- deficient mice compared to WT controls (Fig. 9D). Absolute macrophage 
cell counts at 71dpi were significantly increased in IL-4R-/-/IL-5-/- compared to corresponding 
WT mice (Fig. 9E). At 119dpi no differences in macrophage numbers were present in all 
tested mouse strains (Fig. 9F). A statistically significant increase of eosinophils (Fig. 9G) was 
observed at 71dpi in IL-4R-/- mice compared to WT controls. Absolute eosinophil counts were 
significantly decreased in dblGATA and IL-5-/- animals compared to WT mice (Fig. 9H). 
Eosinophil numbers within the spleen did not correlate with the MF load at 71 (r= 0.12; 
p=0.42; Fig. 9I) and 119dpi (r= -0.26; p=0.10; Fig. 9J), but correlated negatively with the 
adult worm counts at 119dpi (r= -0.49; p=0.001; 71 dpi: r= -0.23; p=0.12; Fig. 9K, L).  
Fig. 8: Neutrophil numbers in the spleen correlate positively with the adult worm burden and 
microfilariae load. Total numbers of spleen cells (A, B) and neutrophils (C, D) in IL-4R-/-, dblGATA, IL-5-/-, 
IL-4R-/-/IL-5-/- mice and wildtype (WT) controls 71 and 119 days post L. sigmodontis infection. Spearman 
correlation of the total neutrophil spleen cell numbers and peripheral blood microfilariae counts (E, F) and adult 
worm burden (G, H) at 71 and 119 days post L. sigmodontis infection in IL-4R-/-, dblGATA, IL-5-/-, IL-4R-/-/IL-
5-/- mice and wildtype controls. Results are shown as medians (A, B, C, D) and Spearman correlation (E, F, G, 
H). Differences were analyzed for statistical significance using the one-way ANOVA followed by the Dunnett’s 
test (B, C, D) and Kruskal-Wallis test followed by the Dunn’s multiple comparison test (A).*p<0.05, **p<0.01, 
***p<0.001. Data in (A, C, E, G) are pooled from two independent experiments at 71dpi with 10-16 mice per 
group. Remaining figures (B, D, F, H) are from one experiment at 119dpi with 6-10 mice per group. 
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3.1.4 Thoracic cavity IL-6 cytokine concentration correlates negatively with MF loads 
Immunological changes within the thoracic cavity cytokine milieu were analysed and 
quantified by lavage, namely the Th1 cytokines IFN-γ and IL-6, as well as the type 2 
cytokines IL-4, IL-5 and IL-13 (Fig. 10) in order to investigate potential correlations between 
those cytokines and microfilaremia as well as adult worm burden. At 71dpi, IFN-γ levels were 
elevated in all tested immune-deficient mouse strains compared to WT controls (Fig. 10A) 
and remained high in IL-4R-/-/IL-5-/- mice at 119dpi (Fig. 10B). Interestingly, IL-6 cytokine 
levels (Fig. 10C, D) showed a strong negative correlation with the MF load (71dpi: r= -0.43, 
p=0.004; 119dpi: r=0.30 p=0.06). No correlations were observed between IL-6 levels and 
adult worm burden at the onset of microfilaremia and the late phase of L. sigmodontis 
infection (71dpi: r= -0.02, p=0.90; 119dpi: r= 0.16, p=0.30). IFN-γ, IL-4, IL-5, and IL-13 
cytokine levels did neither correlate with adult worm burden nor MF load and correlations are 
summarized in table 1. These results indicate that thoracic cavity cytokine levels did not 
Fig. 9: Impact of the lack of IL-5, dblGATA, IL-4R and IL-4R/IL-5 on CD4+ T cell, CD8+ T cell, 
macrophage and eosinophil numbers in the spleen of L. sigmodontis-infected mice. Total spleen cell 
CD4+ T cell (A, B), CD8+ T cell (C, D), macrophage (E, F) and eosinophil numbers (G, H) at 71 and 119 
days post L. sigmodontis infection in IL-4R-/-, dblGATA, IL-5-/-, IL-4R-/-/IL-5-/- mice and wildtype (WT) 
controls. Spearman correlation of the total eosinophil spleen cell numbers and peripheral blood microfilariae 
counts (I, J) and adult worm burden (K, L) at 71 and 119 days post L. sigmodontis infection. Results are 
shown as medians (A-H) and Spearman correlation (I-L). Differences were analyzed for statistical 
significance using the one-way ANOVA followed by the Dunnett’s test (A, D) and Kruskal-Wallis test 
followed by the Dunn’s multiple comparison test (B, C, E, F, G, H).*p<0.05, **p<0.01, ***p<0.001. Data 
in (C, E, G, I, K) are pooled from two independent experiments at 71dpi with 10-16 mice per group; data 
shown in (A) is a representative of two independent experiments with 5-10 mice per group, as it did not pass 
the test for homodesticity. Remaining figures (B, D, F, H, J, L) are from one experiment at 119dpi with 6-
10 mice per group. 
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correlate with the adult worm burden and solely IL-6 correlated negatively with the MF 
counts at 71dpi (Table 1).  
Table 1: Negative correlation of IL-6 thoracic cavity concentrations with the MF load. Spearman 
correlation of IL-4, IL-5, IL-6, IL-13, and IFN-γ cytokine levels within the thoracic cavity lavage at 71 and 119 
days post L. sigmodontis infection with total worm numbers and MF load. 
 
                                                                                                                                                                                                                                    
                                
 
 
 
 
 
 
High IL-13 concentrations in the thoracic cavity lavage were observed in the absence of 
AAMs in IL-4R-/- as well as IL-4R-/-/IL-5-/- mice at 71dpi (Fig. 10I, J), reaching statistically 
significant difference in IL-4R-/-/IL-5-/- mice compared to WT controls at 119dpi (Fig. 10J). 
However, lack of eosinophils in IL-5-/-, IL-4R-/-/IL-5-/- and dblGATA mice did not alter IL-4, 
IL-5, IL-6, or IL-13 cytokine levels (Fig. 10C-J). 
Cytokine  Microfilariae 71dpi  Microfilariae 119dpi  
IL-4  r=0.34  p=0.04  r=-0.04  p=0.79  
IL-5  r=0.10  p=0.62  r=-0.33  p=0.13  
IL-6  r=-0.43  p=0.001  r=0.30  p=0.06  
IL-13  r=0.18  p=0.26  r=0.36  p=0.02  
IFN-y  r=0.03  p=0.84  r=0.16  p=0.34  
Cytokine  Worm burden 71dpi  Worm burden 119dpi  
IL-4  r=0.01  p=0.95  r=0.06  p=0.73  
IL-5  r=0.19  p=0.35  r=-0.34  p=0.11  
IL-6  r=-0.02  p=0.90  r=0.16  p=0.30  
IL-13  r=0.01  p=0.93  r=0.19  p=0.23  
IFN-y  r=0.07  p=0.65  r=-0.04  p=0.81  
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Collectively, these data demonstrate that IL-4R-/-/IL-5-/- mice exhibited the highest 
susceptibility for L. sigmodontis infection due the combined lack of AAMs and eosinophils, 
which resulted in an earlier onset of microfilaremia, development of microfilaremia in all 
animals with highest MF loads, and an extended adult worm survival. 
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Fig. 10: Impact of the lack of IL-5, dblGATA, IL-4R and IL-4R/IL-5 on the thoracic cavity cytokine 
milieu in L. sigmodontis-infected mice. Cytokine concentrations of IFN-γ (A, B), IL-4 (C, D), IL-5 (E, F), 
and IL-13 (G, H) in the thoracic cavity lavage 71 and 119 days post L. sigmodontis infection of wild type 
(WT), IL-4R-/-, dblGATA, IL-5-/- and IL-4R/IL-5-/- mice. Results are shown as median. Differences were 
analyzed for statistical significance using the Kruskal-Wallis test followed by the Dunn’s multiple 
comparison test. *p<0.05, **p<0.01. Data shown in (A, C, E, G) are pooled from two independent 
experiments at 71dpi with 10-16 mice per group. Remaining figures (B, D, F, H) are from one experiment at 
119dpi with 6-10 mice per group. 
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3.2 Impact of S100A8/A9 on L. sigmodontis infection 
3.2.1 Migrating L3 larvae mediate pulmonary inflammation  
A recent study has shown that the migratory phase of infective L3 L. sigmodontis larvae was 
associated with elevated expression of the alarmins S100A8/S100A9 (Calprotectin) in 
neutrophils within the bronchoalveolar lavage. Therefore, the direct impact of Calprotectin 
during L. sigmodontis infection in C57BL/6 mice lacking S100A8/A9 compared to C57/BL6 
WT controls was investigated. 
During the blood meal of the natural arthropod vector O. bacoti, infectious L3 L. sigmodontis 
larvae are transmitted into the skin of the rodent host and migrate via the blood and lymphatic 
system, reaching the pulmonary capillaries and finally the thoracic cavity, where the filarial 
worms reside. As they are known to induce transient pulmonary inflammation during the 
migratory phase, the lung pathology between uninfected (Fig. 11A) and L. sigmodontis-
infected animals was compared (Fig. 11B). Histology was performed by our cooperation 
partner (Dr. Frédéric Fercoq) in Paris. Lungs of L. sigmodontis-infected mice elicited a 
considerable increase of inflamed blood vessels and goblet cells, which were further 
characterized by a higher mucus production (Fig. 11C). The number of congested blood 
vessels (Fig. 11D) and goblet cells was associated with the number of worms reaching the site 
of infection (Fig. 11E) compared to lungs of uninfected animals. Furthermore, the 
perivascular space (PVS) revealed an elevated number of infiltrating immune cells such as 
neutrophils (Fig. 11F, G) and eosinophils (Fig. 11H, I). 
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Fig. 11: Migrating L3 larvae cause transient pulmonary inflammation. C57BL/6 WT and S100A8/A9-/- 
mice were naturally infected with L. sigmodontis. Representative pictures of a lung from an uninfected WT 
mouse (A) and a lung 12 days post natural L. sigmodontis infection of a WT mouse (B) are shown. Number of 
inflamed blood vessels (C, D) and inflamed goblet cells (C, E) from naïve and 12-day L. sigmodontis infected 
mice. Influx of neutrophils (F, G) and eosinophils (H, I) in the perivascular space (PVS) of an intact and 
congested blood vessel. The figures are representative from two experiments with at least 1-3 mice per group. 
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First, the abundance of the damage-associated protein S100A9 was confirmed by histology in 
WT animal lung parenchyma and its absence in S100A8/A9-/- mice lungs (Fig. 12) 
 
 
 
 
3.2.2 S100A8/A9-/- mice show decreased worm burden and increased inflammation  
To investigate the role of S100A8/A9 during filarial infection, WT and S100A8/A9-/- mice 
were infected nat. with L. sigmodontis via the bite of the tropical rat mite. Necropsy at 12dpi 
included enumeration of the worm burden and analysis of the lung pathology by histology, the 
cellular composition, the cytokine profile and enzymes. S100A8/A9-/- mice revealed a 
significantly reduced worm burden compared to WT controls (Fig. 13A). Interestingly, 
S100A8/A9-/- mice suffered less lung pathology, probably due to the decreased worm burden, 
which was further characterized by a reduction of inflamed blood vessels per cm2 in 
comparison to corresponding WT animals (Fig. 13B). S100A8/A9-/- exhibited an increased 
number of total thoracic cavity cells compared to WT controls (Fig. 13C). Flow cytometry 
analysis of the thoracic cavity revealed that frequencies of CD4+ T cells, CD8+ T cells, 
neutrophils, macrophages and eosinophils were comparable between the two tested groups 
(Fig. 13D). However, an increase of neutrophil-associated chemokines CXCL-1 (Fig. 13E), 
 
Fig. 12: S100A9 expression in the lung parenchyma. Representative figure of S100A9 expression in 
uninfected WT (A) and S100A8/A9-/- mice (B) lung parenchyma. 
                  WT                S100A8/A9-/- 
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CXCL-2 (Fig. 13F), CXCL-5 (Fig. 13G), and elastase (Fig. 13H) was observed in the thoracic 
cavity lavage of S100A8/A9-/- mice compared to WT controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13: Reduced worm burden and lung pathology, but increased neutrophil mediator release 
following L3 migration in S100A8/A9-/- mice. Worm burden following natural L. sigmodontis infection in 
WT and S100A8/A9-/- mice at 12 days post infection (A). Total number of inflamed blood vessels (B), 
number of thoracic cavity cells (C) and cellular composition of the thoracic cavity lavage 12 days post L. 
sigmodontis infection in WT and S100A8/A9-/- mice (D). Concentrations of CXCL-1 (E), CXCL-2 (F), 
CXCL-5 (G), and elastase (H) in the thoracic cavity lavage 12 days post L. sigmodontis infection in WT and 
S100A8/A9-/- mice. Results are shown as median (A-C, E-H) or mean with SEM (D). Differences were 
analyzed for statistical significance using the Mann-Whitney U-test *p<0.05, **p<0.01. Data shown are from 
one experiment with 5 mice per group. 
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3.2.3 Subcutaneous infection with L3 larvae results in a reduced worm burden in 
S100A8/A9-/- mice  
In order to elucidate whether the observed protective effect in S100A8/A9-/- mice occurs 
within the skin as the first barrier, WT and S100A8/A9-/- animals were s.c. inoculated with 
infective L3 larvae. S.c. infection of L. sigmodontis L3 larvae resulted in a similar outcome as 
during nat. infection, revealing again a reduced worm burden in S100A8/A9-/- mice (Fig. 
14A). To confirm that the S100A8/A9 dependent mechanism did not occur within the skin, 
immune responses within the skin were assessed 3h after both mouse strains were injected i.d. 
with 10 L3 larvae. I.d. injections of L. sigmodontis L3 larvae in WT and S100A8/A9-/- mice 
led to an increased influx of cells to the site of infection compared to PBS-treated 
corresponding controls. Interestingly, S100A8/A9-/- mice exhibited more cells after PBS and 
L3 injection compared to WT animals (Fig. 14B). Frequencies of eosinophils (Fig. 14C) were 
increased after L3 injection in S100A9-/- mice as well as the frequency of neutrophils (Fig. 
14D) in both mice strains. However, no statistical significant differences between WT and 
S100A8/A9-/- animals were observed following L3 injection with regard to the frequency of 
eosinophils (Fig. 14C), neutrophils (Fig. 14D) and macrophages (Fig. 14E). To assess 
differences in the cell activation, MHCII expression was determined in the measured cell 
frequencies. MHCII expression was increased in eosinophils (Fig. 14F), macrophages (Fig. 
14G) in the skin of L3 larvae injected S100A8/A9-/- animals compared to cells of PBS treated 
S100A8/A9-/- animals. With regard to the cell activation of neutrophils, MHCII expression did 
not differ between PBS and L3 larvae treated WT and S100A8/A9-/- mice (Fig. 14H). 
Collectively, these data revealed that S100A8/A9 does not markedly impacts or increases 
protective immune responses within the skin. 
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Fig. 14: Subcutaneous inoculation of infective L. sigmodontis L3 larvae leads to a reduced worm burden in 
S100A8/A9-/- mice. Worm burden after subcutaneous L. sigmodontis infection in WT and S100A8/A9-/- mice 12 
days post infection (A). Total number of skin cells (B), frequency of eosinophils (C), neutrophils (D) and 
macrophages (E) and their respective MHCII expression (F-H) in WT and S100A8/A9-/- mice 3h post 
intradermal L. sigmodontis injection. Results are shown as median. Differences were analyzed for statistical 
significance using the Mann-Whitney U-test (A). Statistical significance of not normally distributed data (B-H) 
was analyzed by Kruskal-Wallis followed by Dunn’s multiple comparison test *p<0.05, **p<0.01, ***p<0.001. 
Data shown are pooled from two experiments with 8 mice per group (A) and remaining figures from one 
experiment with 5 mice per group (B, C, D, E, F, G, H). 
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To determine a potential role of S100A8/9 within the spleen during L. sigmodontis infection 
and parasite clearance, flow cytometry and splenocyte culture was performed. Absolute 
spleen cell numbers were significantly increased in S100A8/A9-/- animals compared to WT 
mice during nat. infection (data not shown) and s.c. infection (Fig. 15A). No differences were 
observed in the frequencies of CD4+ T cells, CD8+ T cells, macrophages and eosinophils 
between the S100A8/A9-/- mice and WT controls. However, the frequency of neutrophils was 
elevated in S100A8/A9-/- animals compared to corresponding WT mice (Fig. 15B). Upon 
LsAg stimulation for 72h cultured splenocytes of S100A8/9-/- mice produced higher amounts 
of IFN-γ (Fig. 15C) and TNF (Fig. 15D) compared to WT cultured splenocytes. 
 
 
 
 
 
 
 
 
 
 
Fig. 15: Total number of spleen cells in WT and S100A8/A9-/- mice at 12 days post subcutaneous L. 
sigmodontis infection. Total number of spleen cells in WT and S100A8/A9-/- mice (A). Cellular composition in 
spleen (B). Cytokine concentrations of IFN-γ (C) and TNF (D) in 72h spleen culture supernatant upon ConA 
(2.5µg/ml) and LsAg stimulation (25µg/ml). Results are shown as median. Differences were analyzed for 
statistical significance using the Mann-Whitney U-test *p<0.05, **p<0.01. Data shown are pooled from two 
independent experiments with 8 mice per group (A, B) and 4 mice per group (C, D). 
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Furthermore, s.c. infection of L. sigmodontis L3 larvae revealed an increased thoracic cavity 
cell count (Fig. 16A) and no major differences in major cell frequencies (Fig. 16B) within the 
thoracic cavity as observed earlier during nat. L. sigmodontis infection. Total bronchoalveolar 
cell numbers were comparable between WT and S100A8/A9-/- mice (Fig. 16C). However, all 
analysed cell frequencies within the bronchoalveolar lavage were increased in S100A8/A9-/- 
mice (Fig. 16D). 
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Fig. 16: Subcutaneous inoculation of infective L. sigmodontis L3 larvae does not impair immune 
responses at the site of infection. Thoracic cavity cells after subcutaneous L. sigmodontis infection in WT 
and S100A8/A9-/- mice 12 days post infection (A). Thoracic cavity cellular composition (B). Total 
bronchoalveolar cell count (C) and cellular composition (D). Results are shown as median. Differences were 
analyzed for statistical significance using the Mann-Whitney U-test *p<0.05. Data shown are pooled from 
two independent experiments with 4-8 mice per group. 
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3.2.4 Absence of S100A8/A9 within the lung increases pulmonary inflammation during 
migration of infective L. sigmodontis L3 larvae 
To elucidate how S100A8/A9 deficiency impacts immune responses during the migration of 
L. sigmodontis L3 larvae within the lung, we first determined absolute bronchoalveolar cell 
numbers in L. sigmodontis-infected WT and S100A8/A9-/- mice following nat. infection. Total 
bronchoalveolar cell numbers were significantly decreased in S100A8/A9-/- mice (Fig. 17A). 
However, an increase of CD4+ T cell, CD8+ T cell, neutrophil, macrophage, and eosinophil 
frequencies in S100A8/A9-/- mice were observed compared to corresponding WT mice (Fig. 
17B). Bronchoalveolar cell numbers and worm numbers positively correlated at 12dpi in WT 
and S100A8/A9-/- animals during nat. or s.c. L. sigmodontis infection (Fig. 17C). 
Additionally, a strong positive correlation was observed between congested blood vessel 
counts and worm burden (Fig. 17D). Levels of CXCL-1 (Fig. 17E), CXCL-2 (Fig. 17F), 
CXCL-5 (Fig. 17G), and elastase (Fig. 17H) were significantly increased in BAL of 
S100A8/A9-/- animals compared to corresponding WT controls. These results indicate that the 
lung may be involved in the protective immune responses against migrating L. sigmodontis 
L3 larvae. 
 
 
 
 
 
 
 
 
 67 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17: Immune responses to migrating L. sigmodontis L3 larvae within the BAL are increased in 
S100A8/A9-/- mice. Total numbers of bronchoalveolar cells (A) and cellular composition including CD4+ T 
cells, CD8+ T cells, neutrophils, macrophages, and eosinophils (B) in WT and S100A8/A9-/- mice 12 days 
post L. sigmodontis infection. Spearman correlation of total bronchoalveolar cells and worm counts (C) as 
well as congested blood vessels and worm counts (D) obtained 12 days post L. sigmodontis infection. 
Concentrations of CXCL-1 (E), CXCL-2 (F), CXCL-5 (G), and elastase (H) in the bronchoalveolar lavage 
12 days post L. sigmodontis infection of WT and S100A8/A9-/- mice. Results are shown as median (A, C-H) 
or mean with SEM (B). Differences were analyzed for statistical significance using the Mann-Whitney U-test 
*p<0.05, **p<0.01. Data shown in figure (A) and (B) are pooled from two experiments with 2-3 mice per 
group. Remaining figures consist of two or three independent experiments with 3-8 mice per group. 
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As the frequency of neutrophils and production of neutrophil-associated chemokines in the 
BAL and thoracic cavity were increased in S100A8/A9-/- animals, the neutrophil activation of 
S100A8/A9-/- and WT mice was assessed. Neutrophils isolated 12dpi from the BAL of 
S100A8/A9-/- mice did not show any differences in the expression of CD40 (Fig. 18A). 
However, bone-marrow-derived neutrophils of S100A8/A9-/- animals showed a statistical 
significant increased expression of CD40 upon LPS and LsAg stimulation (Fig. 18B). CD86 
showed a statistical significant increase (Fig. 18C) following in vitro stimulation with LPS 
and even under unstimulated conditions compared to WT mice. The increased activation of 
S100A8/A9-/- neutrophils was associated with an increased apoptosis, revealing an elevated 
frequency of dying and dead neutrophils lacking S100A8/A9 (Fig. 18D). Additionally, an 
elevated level of myeloperoxidase (MPO), an enzyme which is abundantly expressed in 
neutrophils and elicits protective properties in the elimination of bacteria and other pathogens, 
was observed from neutrophils of S100A8/A9-/- animals compared to WT neutrophils 
following LPS and LsAg stimulation as well as under unstimulated conditions (Fig. 18E). In 
order to investigate whether these changes in neutrophil activation may affect NET formation 
and L3 larvae motility, which represent an essential tool in the capture and elimination of 
invading pathogens, L3 larvae were cultured in the presence of neutrophils from WT and 
S100A8/A9-/- mice. Interestingly, S100A8/A9-/- neutrophils revealed an earlier inhibition of 
L3 larvae motility in comparison to L3 larvae cultured with neutrophils of WT mice. In order 
to investigate DNA dependency of the inhibitory effect of S100A8/A9-/- neutrophils, DNAse 
was added. The addition of DNAse improved L3 motility in the presence of S100A8/A9-/- 
neutrophils (Fig. 18F). Similar to above mentioned results on neutrophil activation, 
S100A8/A9-/- neutrophils cultured with L3 larvae had an increased MHCII expression 
compared to neutrophils of WT animals (Fig. 18G). Collectively, these data indicate that 
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neutrophils from S100A8/A9-/- animals exhibit an increased activation and inhibit L3 larvae 
motility more effectively.  
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Fig. 18: Increased activation and apoptosis of S100A8/A9-/- neutrophils. Ex vivo CD40 expression of 
neutrophils 12 days post L. sigmodontis infection of WT and S100A8/A9-/- mice (A). CD40 (B) and CD86 (C) 
expression as well as apoptosis (D) of bone marrow-derived neutrophils from WT and S100A8/A9-/- mice after 7h 
of in vitro culture without stimulation (US) or with LPS or LsAg stimulation. Myeloperoxidase concentration of 
WT and S100A8/A9-/- neutrophils upon 7h LPS and LsAg in vitro stimulation (E). Motility score of L3 larvae 
cultured in the presence of WT or S100A8/A9-/- neutrophils +/- DNAse (F) and MHCII expression (G) from WT 
and S100A8/A9-/-. Results are shown as median (A, F, G), mean with SEM (B-D). Differences were analyzed for 
statistical significance using the Mann-Whitney U-test *p<0.05, **p<0.01, ***p<0.001. Data shown in (A, B, C) 
are pooled from 2-3 independent experiments with at least 2-3 mice per group. Remaining figures consist of one 
experiment with 3-4 mice per group. 
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3.2.5 Depletion of neutrophils of the lung abrogates the S100A8/A9-mediated protective 
effect 
As S100A8/A9-/- neutrophils exhibited an increased activation and inhibition of L3 motility in 
vitro, depletion of neutrophils within the lung was performed by intranasal injection of an 
anti-Ly6G antibody during the early phase of L. sigmodontis infection. Neutrophil depletion 
was performed in order to investigate whether neutrophil absence abrogates the protective 
effect on the worm burden. Control animals were treated with an isotype control. As expected, 
isotype treated S100A8/A9-/- animals exhibited a reduced worm burden compared to WT mice 
at 12dpi (Fig. 19A). Interestingly, the depletion of neutrophils in S100A8/A9-/- mice led to a 
significant increase of worm recovery compared to isotype treated S100A8/A9-/- controls, 
revealing a similar worm burden compared to isotype-treated WT mice (Fig. 19A). 
Furthermore, an association was observed between the increased worm burden in neutrophil-
depleted S100A8/A9-/- mice, the elevated number of inflamed blood vessels (Fig. 19B) and an 
increased lung pathology (Fig. 19C). In summary, these findings suggest that bronchoalveolar 
neutrophils mediate protective immune responses against invading L3 larvae in S100A8/A9-/- 
animals. 
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Fig. 19: Depletion of neutrophils during the early phase of L. sigmodontis infection abrogates the 
S100A8/A9-mediated reduction in worm burden. Worm burden 12 days post L. sigmodontis infection of WT 
and S100A8/A9-/- mice intranasally treated with anti-Ly6G to deplete lung neutrophils and isotype-treated 
controls (A) and total number of inflamed blood vessels (B). Representative picture of a lung isolated from a 12-
day L. sigmodontis-infected S100A8/A9-/- mouse treated with isotype controls or anti-Ly6G (C). Statistical 
significance of not normally distributed data was analyzed by Kruskal-Wallis followed by Dunn’s multiple 
comparison test (A, B). Data shown are pooled from two independent experiments with at least 5 mice per group. 
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3.2.6 Increased worm burden in S100A8/A9-/- mice upon intravenous injection of L3 
larvae  
To determine, if the protective mechanism observed in S100A8/A9-/- mice resulting in a 
decreased worm burden, is induced due to the consecutive entrance of L3 larvae from the 
pulmonary capillaries into the thoracic cavity, WT and S100A8/A9-/- mice were infected i.v. 
with 40 L3 larvae. I.v. injection of L3 larvae revealed an increased worm burden in 
S100A8/A9-/- animals compared to WT mice (Fig. 20A). This phenotype may occur due to the 
simultaneous entrance of the L3 larvae within the pulmonary capillaries into the thoracic 
cavity, preventing the timely initiation of protective immune responses against invading L3 
larvae. During nat. and s.c. infection, infective L3 larvae reach the thoracic cavity between 2-
6dpi, enabling the generation of protective immune responses against larvae that enter at a 
later time-point. Although i.v. infected S100A8/A9-/- mice exhibited an increased worm 
burden, similar immune responses within the thoracic cavity were observed following nat. and 
s.c. infection. Thoracic cavity cells (Fig. 20B) were increased as well as levels of elastase 
(Fig. 20C) and CXCL-2 (Fig. 20D) within the pleural lavage.  
Total bronchoalveolar cell counts did not show any differences between WT and S100A8/A9-
/- mice (Fig. 20E). However, elevated levels of CXCL-1 (Fig. 20F) and CXCL-5 (Fig. 20G) 
were observed within the bronchoalveolar lavage of S100A8/A9-/- compared to WT controls. 
These results indicate that the protective effect observed in S100A8/A9-/- mice is abrogated 
after i.v. infection. 
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Fig. 20: Simultaneous entry of infective L. sigmodontis L3 larvae during intravenous injection leads to an 
increased worm burden in S100A8/A9-/- mice. Total number of worms in WT and S100A8/A9-/- mice 12 days 
post intravenous infection (A). Total number of thoracic cavity cells (B), concentrations of elastase (C) and 
CXCL-2 (D) in the thoracic cavity lavage as well as total number of bronchoalveolar cells (E), concentrations 
of CXCL-1 (F) and CXCL-5 (G) in BAL of 12-day L. sigmodontis-infected WT and S100A8/A9-/- mice. Figure 
A is shown as median. Remaining figures are shown as mean with SEM. Differences were analyzed for 
statistical significance using the Mann-Whitney U-test *p<0.05, **p<0.01, ***p<0.001. Data shown are pooled 
from two independent experiments with 5-8 mice per group. 
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3.2.7 Decreased inflammation in S100A8/A9-/- mice during the late phase of L. 
sigmodontis infection 
Next, the role of S100A8/A9 during the molting of L4 L. sigmodontis larvae into adult worms 
(29dpi) was investigated. Analysis included worm counts, immune responses within the 
bronchoalveolar and thoracic cavity lavage at a time point at which L4 larvae molt in WT 
mice into adult male and female worms.  
Comparable to the results at 12dpi the worm burden was significantly decreased in 
S100A8/A9-/- animals compared to WT mice at 29dpi (Fig. 21A). Furthermore, a lower 
amount of infiltrated cells, especially eosinophils, was observed in the perivascular space of 
WT mice, indicating a reduction in lung pathology (Fig. 21B). Analysis of the thoracic cavity 
lavage showed a significantly increased cell count in S100A8/A9-/- animals compared to WT 
controls (Fig. 21C). Frequencies of eosinophils, neutrophils and macrophages within the 
thoracic cavity at 29dpi were significantly decreased in S100A8/A9-/- mice in comparison to 
WT mice (Fig. 21D). Furthermore, no differences were observed for total bronchoalveolar 
cell numbers (Fig. 21E) and frequencies of eosinophils, neutrophils and macrophages (Fig. 
21F) between both mouse strains. Interestingly, neutrophils in S100A8/A9-/- mice within the 
thoracic cavity (Fig. 21G) and bronchoalveolar lavage (Fig. 21H) were less activated 
compared to neutrophils of WT mice. 
Collectively, these results indicate that at day 29dpi S100A8/A9 is rather involved during the 
early time point of infection, especially during the transient pulmonary inflammation caused 
by migrating infective L3 L. sigmodontis larvae. 
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In summary, the data of this project demonstrate a pulmonary protective role of S100A8/A9 
that inhibits L3-induced inflammation within the lung by decreasing chemokine production, 
granulocyte recruitment and furthermore neutrophil activation in vitro and ex vivo, reducing 
transient inflammatory responses and therefore facilitating larval migration. 
 
 
 
 
 
 
 
 
 
Fig. 21: Impact of S100A8/A9 on worm recovery and cellular responses in the thoracic cavity and 
bronchoalveolar lavage 29 days post L. sigmodontis infection. Worm burden in WT and S100A8/A9-/- 
mice 29 days post natural L. sigmodontis infection (A) and inflamed pulmonary blood vessels 29 days 
following L. sigmodontis infection in WT mice (B). Total number of thoracic cavity (C) and 
bronchoalveolar cells (E) as well as frequencies of indicated cell populations in thoracic cavity lavage 
(D) and bronchoalveolar lavage (F) as well as neutrophil MHCII expression in thoracic cavity (G) and 
bronchoalveolar lavage (H) in WT and S100A8/A9-/- mice 29 days post natural L. sigmodontis infection. 
Results are shown as median. Differences were analyzed for statistical significance using the Mann-
Whitney U-test *p<0.05, **p<0.01, ***p<0.001. Data shown are from one experiment with 9 mice per 
group. 
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3.3 Impact of AhR on L. sigmodontis infection 
3.3.1 Deficiency of the aryl hydrocarbon receptor increases L. sigmodontis susceptibility  
In the course of evolution eukaryotes developed different kind of cellular sensors including 
AhR, for the perception of external agents such as harmful agents, pathogens and toxins. As 
AhR is widely expressed within lung and skin, which represent the migration pathway of 
infective L3 L. sigmodontis larvae, it was aimed to identify its role during filarial infection. 
Therefore, AhR-/- mice were nat. infected with the murine filarial nematode L. sigmodontis. 
During necropsies at 5 and 14dpi worm numbers were assessed and the immune responses at 
the site of infection, the thoracic cavity, within the lung as well as spleen were analyzed. The 
worm burden was statistically significant increased in AhR-/- mice at 5 (median values AhR-/-: 
7/ WT: 5.2) and 14dpi (median values AhR-/-: 18.6/ WT: 10.6) compared to WT controls (Fig. 
22). 
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Fig. 22:  Increased L. sigmodontis worm burden in AhR-/- mice. Worm burden following natural L. 
sigmodontis infection in WT and AhR-/- mice at 12 days post infection. Results are shown as median. 
Differences were analyzed for statistical significance using the Mann-Whitney U-test. *p<0.05. Data shown 
are pooled from 2-3 independent experiments with 5-7 mice per group. 
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3.3.2 AhR deficiency impairs immune responses within the thoracic cavity, lung and 
spleen  
In order to investigate whether AhR-related changes in cellular composition and cytokine 
milieu are associated with the increased worm burden in AhR-/- mice, thoracic cavity, 
bronchoalveolar and spleen cells were analyzed by flow cytometry as well as cytokine 
profiles from the lavages at 5 and 14dpi. Uninfected AhR-/- mice did not show any differences 
in major immune cell frequencies of the thoracic cavity lavage compared to WT controls 
except for CD4+ T cell frequencies, which were significantly lower compared to WT CD4+ T 
cell frequencies (Fig. 23A). Thoracic cavity cell counts were significantly increased in AhR-/- 
mice in comparison to WT controls at 5 and 14dpi (Fig. 23B). This increase was associated 
with a higher frequency of macrophages in AhR-/- mice compared to WT controls during both 
time points (Fig. 23C, E). In contrast, frequencies of CD4+ T cells (p<0.001), eosinophils 
(p<0.05) and neutrophils (p<0.05) within the thoracic cavity were decreased in AhR-/- mice at 
5dpi (Fig. 23C), reaching statistical significant differences at 14dpi compared to 
corresponding WT controls (Fig. 23E). Interestingly, MHCII expression was significantly 
lower for eosinophils, neutrophils and macrophages in AhR-/- mice at 5dpi compared to WT 
controls, indicating a reduced activation (Fig. 23D). MHCII expression in macrophages of 
AhR-/- animals was still decreased at 14dpi compared to WT mice (Fig. 23F). 
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Fig. 23: Impaired immune responses in the thoracic cavity of AhR-/- mice. Cellular composition of the 
thoracic cavity lavage in naive WT and AhR-/- mice (A). Total number of thoracic cavity cells (B) and cellular 
composition of the thoracic cavity lavage (C) in 5 day L. sigmodontis infected mice as well as MHCII expression 
of macrophages, eosinophils and neutrophils (D). Cellular composition of the thoracic lavage (E) 14 days post L. 
sigmodontis infection and MHC expression of macrophages (F). Results are shown as mean with SEM. 
Differences were analyzed for statistical significance using the Mann-Whitney U-test *p<0.05, ***p<0.001. 
Data shown are pooled from two independent experiments with 5-7 mice per group. 
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Cytokine analysis of the pleural lavage for IL-4, IL-5, IL-6, IL-13, IFN-γ, TNF, and IL-1β 
were under the detection limit for naïve and infected WT and AhR-/- animals (data not 
shown). As AhR has been known to play a crucial role during attraction of several cell types 
during inflammatory processes, two prominent and AhR-associated chemokines were 
measured. Concentrations of CCL17 showed comparable values for AhR-/- and WT mice at 
5dpi, but was significantly lower in AhR-/- at 14 dpi (Fig. 24A). In contrast, CXCL-10 was 
significantly increased at 5dpi in AhR-/- mice compared to WT controls, which was still 
elevated at 14dpi (Fig. 24B). 
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Similar to the pleural cavity cells, isolated bronchoalveolar and spleen cells were analyzed. 
Total bronchoalveolar cell counts (Fig. 25A) and cellular composition, including frequencies 
of CD4+ T cells, eosinophils, neutrophils and macrophages were comparable between 
uninfected AhR-/- and WT animals (Fig. 25B). At 5dpi bronchoalveolar frequencies of 
macrophages and eosinophils were decreased in AhR-/- mice compared to WT controls, 
whereas frequencies of neutrophils were increased in AhR-/- animals (Fig. 25C). The 
Fig. 24: AhR deficiency decreases CCL17 and increases CXCL-10 concentrations in the thoracic 
cavity lavage of L. sigmodontis infected mice. Concentrations of CCL17 (A) and CXCL-10 (B) in 5 and 
14-day L. sigmodontis infected WT and AhR-/- mice. Results are shown as mean with SEM. Differences 
were analyzed for statistical significance using the Mann-Whitney U-test *p<0.05. Data shown are pooled 
from two independent experiments with 5-7 mice per group. 
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decreased frequency of macrophages in AhR-/- at 5dpi was further associated with an 
increased MHCII expression in AhR-/- mice in comparison to WT animals. However, MHCII 
expression in neutrophils and eosinophils at 5dpi were comparable between both mouse 
strains (Fig. 25D). 
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ELISA results from the bronchoalveolar lavage revealed statistically significant lower 
concentrations of CCL17 (Fig. 26A) and CXCL-10 (Fig. 26B) at 5dpi in AhR-/- compared to 
Fig. 25: Absence of AhR impairs the influx of macrophages and eosinophils during early L. 
sigmodontis infection within the bronchoalveolar lavage. Total number of bronchoalveolar cells (A). 
Cellular composition of the bronchoalveolar lavage in uninfected animals (B). Cellular composition of the 
bronchoalveolar lavage (C) and MHCII expression of macrophages, neutrophils and eosinophils (D) 5 days 
post L. sigmodontis infection of WT and AhR-/- mice. Results are shown as mean with SEM. Differences 
were analyzed for statistical significance using the Mann-Whitney U-test *p<0.05, **p<0.01. Data shown 
(A, B) consist of one experiment with 4 mice per group. Remaining data shown are pooled from two 
independent experiments with 3-4 mice per group (C, D). 
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WT mice. The difference vanished during the later time point of infection at 14dpi (data not 
shown). 
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With regard to immunological changes within the spleen of naïve animals no differences in 
frequencies of CD4+ T cells and eosinophils were observed between both mouse strains. 
However, frequencies of neutrophils and macrophages were significantly increased in naïve 
AhR-/- animals compared to naïve WT controls (Fig. 27A). L. sigmodontis infection led to an 
increase of total splenocyte number in AhR-/- mice in comparison to WT controls (Fig. 27B). 
At 5 days post L. sigmodontis infection frequencies of CD4+ T cells, eosinophils and 
macrophages in AhR-/- animals were significantly lower compared to WT mice (Fig. 27C). 
These observations were further associated with a lower MHCII expression by eosinophils 
and macrophages in AhR-/- animals (Fig. 27D). These differences vanished at 14dpi and 
frequencies of macrophages were increased in AhR-/- mice compared to WT mice at 14dpi 
Fig. 26:  AhR deficiency decreases CCL17 and CXCL-10 concentrations in the bronchoalveolar 
lavage. Concentrations of CCL17 (A) and CXCL-10 (B) in the bronchoalveolar lavage of 5 day-L. 
sigmodontis-infected WT and AhR-/- mice. Results are shown as mean with SEM. Differences were 
analyzed for statistical significance using the Mann-Whitney U-test *p<0.05. Data shown are pooled from 
two independent experiments with 3-4 mice per group. 
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(Fig. 27E). Neutrophil frequencies during both time points at 5 and 14dpi did not reveal any 
statistical differences between immunodeficient and control mice. 
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Fig. 27: Reduced macrophage and eosinophil frequencies within the spleen of AhR-/- mice during early 
L. sigmodontis infection. Cellular composition of the spleen in uninfected WT and AhR-/- animals (A). 
Total number of splenocytes (B) and cellular composition of the spleen (C) 5 days post L. sigmodontis 
infection and MHCII expression of eosinophils, neutrophils and macrophages (D) of WT and AhR-/- mice. 
Cellular composition of the spleen (E) 14 days post L. sigmodontis infection in WT and AhR-/- mice. Results 
are shown as mean with SEM. Differences were analyzed for statistical significance using the Mann-
Whitney U-test *p<0.05, **p<0.01, ***p<0.001. Data shown in (A, B) are from one experiment with 5 mice 
per group. Remaining data (C-E) are pooled from 2-3 independent experiments with 5-7 mice per group. 
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3.3.3 Impaired immune responses within the skin of AhR-/- mice 
Since AhR is highly expressed on various cell types within the skin including dendritic cells, 
monocytes and macrophages, the immune responses within the skin in AhR-/- mice after i.d. 
injection of L. sigmodontis crude extract was determined. After 3h post injection the skin 
tissue was isolated, digested and immune cells were analyzed by flow cytometry. I.d. 
injections of L. sigmodontis L3 larvae increased the influx of cells to the site of infection in 
WT and AhR-/- mice compared to controls treated with PBS. Cellular influx in the skin of 
AhR-/- mice after PBS and L3 larvae injection was lower compared to WT controls, indicating 
an impaired influx of immune cells within the skin of AhR-/- (Fig. 28A). Interestingly, the 
impaired influx of immune cells in AhR-/- mice was further associated with decreased total 
cell counts of monocytes (Ly6C+/F4/80-, Fig. 28B), macrophages (F4/80+/SiglecF-, Fig. 
28C), neutrophils (Ly6G+/CD11b+, Fig. 28D) and eosinophils (SiglecF+/F4/80-, Fig. 28E) 
following LsAg injection compared to corresponding WT mice. Furthermore, these decreased 
cell frequencies in LsAg-injected AhR-/- mice were accompanied by a lower cell activation 
state, revealing a decreased expression of CD86 on monocytes (Fig. 28F), MHCII on 
macrophages (Fig. 28G), and CD69 on neutrophils (Fig. 28 H). No differences were observed 
in the cell activation state of CD54 in the frequency of eosinophils (Fig. 28I). 
These results indicate that immune responses within the skin of AhR-/- mice are impaired 
following L3 injection, resulting in an impaired influx of immune cells as well as less 
activated monocytes, macrophages, neutrophils and eosinophils. 
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Fig. 28: AhR-/- impairs immune responses within the skin. Total number of skin cells (A), monocytes (B), 
macrophages (C), neutrophils (D) as well as eosinophils (E) and their respective CD86 (F), MHCII (G), CD69 
(H) and CD54 (I) expression in WT and AhR-/- mice 3h post intradermal L. sigmodontis infection. Results are 
shown as mean with SEM. Statistical significance of not normally distributed data (A-I) was analyzed by 
Kruskal-Wallis followed by Dunn’s multiple comparison test *p<0.05, ** p<0.01. Data shown are from one 
experiment with 5 mice per group. 
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3.3.4 AhR deficiency impairs macrophage activation upon LPS and LsAg stimulation 
Macrophages belong to the main antigen-presenting cells and expand during L. sigmodontis 
infection as AAMs within the thoracic cavity. Since AhR is highly expressed in myeloid cell 
types, especially macrophages, and a reduced cell activation of macrophages was observed 
following i.d. LsAg injection and within the spleen as well as thoracic cavity in AhR-/- mice, 
cell activation was assessed in vitro of bone-marrow-derived macrophages from WT and 
AhR-/- mice upon LPS and LsAg stimulation. Macrophages of AhR-/- mice exhibited a 
decreased expression of CD86 (Fig. 29A) and MHCII (Fig. 29B) after 3h of LPS and LsAg 
stimulation compared to macrophages of WT animals. Although, TNF levels were decreased 
in AhR-/- mice following LsAg stimulation, the difference was not statistically significant 
compared to WT animals (Fig. 29C).  
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Fig. 29: Absence of AhR impairs macrophage activation. Expression of CD86 (A) and MHCII (B) 
on bone-marrow derived macrophages WT and AhR-/- mice and concentration of released TNF (C) 3h 
post in vitro culture. Results are shown as mean with SEM. Differences were analyzed for statistical 
significance using the Mann-Whitney U-test *p<0.05. Data shown are from one experiment with 3 mice 
per group. 
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Collectively, these data indicate that the absence of AhR impairs cell activation of 
macrophages and further the release of inflammatory cytokines such as TNF in response to 
LsAg. 
3.3.5 AhR deficiency increases vascular permeability and facilitates larval migration 
Next it was set out to investigate if the absence of AhR impact vascular permeability which 
may facilitate L. sigmodontis L3 migration. PBS and LsAg i.d. injected ears of AhR-/- mice 
and corresponding WT controls were isolated 10min after i.v. injection of Evans blue 
(30mg/kg). After incubation at 56°C for 24h the optical density was determined in order to 
analyse in vivo vascular permeability. I.d. injections of LsAg increased OD values in WT and 
AhR-/- mice compared to controls treated with PBS. Interestingly, injection of LsAg revealed 
a significant increase of vascular permeability in AhR-/- mice compared to WT LsAg treated 
animals, which may facilitate L3 larval migration (Fig. 30). 
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Fig. 30: Increased vascular permeability in AhR-/- animals. Optical density in PBS and LsAg-treated WT and 
AhR-/- animals. Results are shown as mean with SEM. Differences were analyzed for statistical significance 
using the Mann-Whitney U-test *p<0.05, ** p<0.01, *** p<0.001. Data shown are pooled from two independent 
experiments with 4-5 mice per group. 
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In conclusion, several protective mechanisms related to AhR during L. sigmodontis infection 
have been identified. First of all AhR deficiency led to reduced cell activation as well as 
limited immune responses within the skin. In addition, this was also associated with an 
enhanced vascular permeability in AhR-/- compared to WT controls, which facilitated larval 
migration and resulted in an increased worm burden during early timepoint of L. sigmodontis 
infection. 
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3.4 LsAg and diet-induced insulin-resistance 
3.4.1 LsAg administration improves glucose, but not insulin tolerance 
Recent studies have shown that helminth infections and worm-derived products may be 
beneficial to ameliorate T2D by improving insulin and glucose tolerance. However, further 
investigations based on the protective mechanism are still rare. Berbudi and colleagues 
demonstrated that the repeated administration of adult worm extract (LsAg) improved glucose 
tolerance in diet-induced obese (DIO) mice, which was further associated with an increase of 
eosinophils and AAMs within the adipose tissue [118]. Therefore, it was investigated whether 
LsAg may have an impact on other cell frequencies as T cells, which could be associated with 
the improved glucose tolerance due to LsAg treatment after the onset of obesity. After the 
repeated administration of LsAg in obese mice a glucose and insulin tolerance test was 
performed. DIO mice reached highest glucose concentrations 15-30min after glucose 
challenge. Afterwards, glucose levels in DIO mice treated i.p. with LsAg declined steadily 
compared to blood glucose levels of DIO mice treated with PBS (Fig. 31A). These results 
indicated an improved glucose tolerance. The AUC (area under the curve) showed 
significantly lower values in LsAg-treated DIO mice compared to PBS-treated DIO controls 
(Fig. 31B).  
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Fig. 31: Intraperitoneal administration of LsAg improves glucose intolerance in HFD mice. Blood glucose levels 
over the time after intraperitoneal glucose challenge in intraperitoneally PBS- (NFD, HFD) and LsAg-administered 
HFD mice after 16 weeks of HFD (A). Calculated area under curve (AUC) from the course of glucose tolerance test 
(B). Results are shown as mean +/- SEM (A) and mean with + SEM (B). Differences were analyzed for statistical 
significance using 1-Way ANOVA followed by Dunnett’s test. *p<0.05, ***p<0.001. Data shown are pooled from two 
independent experiments with 6 mice per group. 
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In addition, an insulin tolerance test (ITT) similar to the GTT was performed, during which 
insulin was injected and glucose blood levels were measured at regular intervals. Lowest 
glucose concentration was observed in DIO mice at 30min after insulin challenge. 
Subsequently, glucose concentration increased constantly until 120min after insulin challenge. 
No statistical differences were observed in blood glucose levels at the different time points of 
LsAg and PBS treated DIO mice (Fig. 32A). The AUC for the ITT showed a significant lower 
value of NFD-PBS treated mice compared to corresponding PBS-treated DIO mice (Fig. 
32B). 
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Fig. 32: LsAg does not improve insulin sensitivity in HFD mice. Blood glucose levels over time after 
intraperitoneal insulin injection in LsAg and PBS intraperitonealy administered HFD mice after 16 weeks 
of HFD (A). Calculated area under curve from the course of the insulin tolerance test (B). Results are 
shown as mean +/- SEM (A) and mean + SEM (B). Differences were analyzed for statistical significance 
using 1-Way ANOVA followed by Dunnett’s test. ***p<0.001. Data shown are pooled from two 
experiments with 6 mice per group. 
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Repeated s.c. treatment of LsAg in DIO treated mice did not improvethe glucose tolerance 
compared to PBS controls (Fig. 33A, B). 
 
 
 
 
 
3.4.2 LsAg administration alters adipose tissue T cell frequencies 
Obesity leads to chronic inflammation resulting in a pro-inflammatory milieu by altering the 
cellular composition of the adipose tissue, replacing AAMs by infiltrated classically activated 
macrophages, increasing CD8+ T cell and Th1 cell frequencies and decreasing regulatory 
CD4+ T cell frequencies. Recent studies confirmed the essential role of T cells during diet-
induced inflammatory responses [110] and showed that depletion of CD8+ T cells decreases 
adipose tissue inflammation [107]. Therefore, CD4+ and CD8+ T cell frequencies and pro-
inflammatory cytokine secretion from CD4+ and CD8+ T cells were determined from adipose 
tissue. Repeated administration of LsAg increased frequencies of CD4+ T cells (Fig. 34A), 
whereas CD8+ T cell frequencies declined (Fig. 34B). 
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Fig. 33: Subcutaneous administration of LsAg does not impact glucose tolerance in HFD mice. 
Blood glucose levels over time after intraperitoneal glucose challenge in PBS- and LsAg- subcutaneously 
administered HFD mice after 16 weeks of HF diet (A). Calculated area under the curve (AUC) from the 
course of glucose tolerance test (B). Results are shown as mean +/- SEM (A, B). Differences were 
analyzed for statistical significance using 1-Way ANOVA followed by Dunnett’s test. **p<0.01. Data 
shown consist of one experiment with 6 mice per group. 
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Repeated LsAg administration increased IL-4+ CD4+ T cells (Fig. 35A) and decreased IL-
17+ (Fig. 35B), TNF+ (Fig. 35C) and IFN-γ+ (Fig. 35D) CD4+ T cell frequencies in adipose 
tissue compared to PBS-treated HFD mice.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 34: Repeated administrations of LsAg alters adipose tissue CD4+ and CD8+ T cell frequencies. 
Frequency of CD4+ T cells (A) and CD8+ T cells (B) within the visceral adipose tissue of mice fed on a normal 
chow diet (NFD) or high fat diet (HFD) for 16 weeks and treated with LsAg. Results are shown as mean + 
SEM. Differences were analyzed for statistical significance using 1-Way ANOVA followed by Dunnett’s test. 
**p<0.01, ***p<0.001. Data shown are pooled from two independent experiments with 6 mice per group. 
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Next the frequencies of IFN-γ+, TNF+ and IL-17+ CD8+ T cells were determined. First of all 
it was shown that the frequency of IFN-γ+ CD8+ T cells was not influenced by the repeated 
administration of LsAg compared to PBS-treated HFD mice (Fig. 36A). However, LsAg 
treatment revealed decreased frequencies of TNF+ (Fig. 36B) and IL-17+ (Fig. 36C) CD8+ T 
cells compared to HFD-PBS treated animals.  
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Fig. 35: LsAg treatment reduces pro-inflammatory cytokine production by CD4+ T cells in adipocytes. 
Frequencies of IL-4+ (A), IL-17+ (B), TNF+ (C) ,and IFN-γ+ (D) CD4+ T cells within the adipose tissue of 
animals receiving a normal food diet (NFD) and treated with PBS and high-fat diet (HFD) fed animals for 16 
weeks that were treated daily for 2 weeks intraperitoneal with LsAg or PBS. Results are shown as mean + 
SEM. Differences were analyzed for statistical significance using 1-Way ANOVA followed by Dunnett’s test 
(A, B, D) and Kruskal-Wallis followed by the Dunn’s multiple comparison test (C).*p<0.05, **p<0.01, 
***p<0.001. Data shown are pooled from two independent experiments with 6 mice per group. 
 
 
 
Fig. 36: LsAg treatment reduces pro-inflammatory cytokine production by CD8+ T cells in adipocytes. 
Frequencies of IFN-γ+ (A), TNF+ (B) ,and IL-17+ (C) CD8+ T cells within the adipose tissue of animals 
receiving a normal food diet (NFD) and treated with PBS and high-fat diet (HFD) fed animals for 16 weeks that 
were treated daily for 2 weeks intraperitoneal with LsAg. Results are shown as mean + SEM. Differences were 
analyzed for statistical significance using 1-Way ANOVA followed by Dunnett’s test (A, C) and Kruskal-Wallis 
followed by the Dunn’s multiple comparison test (B). *p<0.05. Data shown are pooled from two independent 
experiments with 6 mice per group. 
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Collectively, these results highlight the protective impact of LsAg in DIO mice, improving 
glucose tolerance as well as alleviating inflammation by decreased pro-inflammatory cytokine 
producing CD4+ (TNF+, ,IFN-γ+, IL-17+) and CD8+ (TNF+, IL-17+) adipose tissue T cells 
during the onset of obesity. 
3.4.3 LsAg administration does not modulate the lipid profile during diet-induced 
obesity 
Since obesity is associated with changes within the lipid profile, it was assessed if the 
repeated administrations of LsAg have an impact on the lipid profile during DIO. Therefore, 
cholesterol, triglycerides and low density lipids (LDL) were measured in the serum. As 
expected, PBS treated controls that were maintained on a chow diet showed lower levels of 
cholesterol, triglyceride and LDL compared to the animals receiving 16 weeks of HFD. No 
statistical differences in total cholesterol (Fig. 37A), triglyceride (Fig. 37B) and LDL (Fig. 
37C) levels in DIO mice that were treated with LsAg in comparison to PBS-treated DIO 
controls were observed, suggesting no impact of LsAg treatment on the lipid profile during 
the onset of obesity.  
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3.4.4 LsAg increases adiponectin levels and dampen CD4 and CD8 T cell inflammation 
In order to investigate potential protective mechanisms induced by LsAg treatment, the 
impact of the regulatory cytokine IL-10 and the most prominent adipokine (Acrp30) were 
investigated. Acrp30 levels were measured in the adipose tissue supernatant and serum of 
LsAg and PBS-treated NFD controls and DIO mice that were fed for 16 weeks with HFD. 
Adipose tissue Acrp30 levels were increased in the LsAg group in comparison to PBS treated 
DIO mice; however no statistical significances were observed (Fig. 38A). A similar increase 
was observed for Acrp30 in the serum of LsAg DIO treated animals compared to PBS-
Fig. 37: Repeated LsAg administrations do not modulate the lipid profile in DIO mice. Concentrations of 
cholesterol (A), triglyceride (B) and LDL Friedewald (C) in peripheral blood of animals receiving a chow diet 
(NFD) and treated with PBS and high-fat diet (HFD) fed animals for 16 weeks that were treated daily for 2 
weeks intraperitoneal with PBS or LsAg. Results are shown as mean + SEM. Differences were analyzed for 
statistical significance using 1-Way ANOVA followed by Dunnett’s test. ***p<0.001. Data shown are pooled 
from two independent experiments with 6 mice per group. 
 
 
. 
 
 96 
 
administered DIO mice (Fig. 38B). Furthermore, LsAg treatment of DIO mice increased 
adipose tissue supernatant IL-10 levels (Fig. 38C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Therefore, the impact of adipocyte supernatants from LsAg and PBS treated animals on CD4 
and CD8 T cell inflammation was further investigated. First splenic CD4+ and CD8+ T cells 
were stimulated with PMA/ionomycin in the presence of adipocyte conditioned media from 
PBS-treated HFD mice and LsAg-treated DIO mice to investigate if the conditioned adipocyte 
media alters T cell cytokine production. Interestingly, adipocyte-conditioned media from 
LsAg decreased pro-inflammatory CD4+ and CD8+ T cell inflammation based on IFN-γ, 
TNF- and IL-17-positve CD4+ and CD8+ T cells, reaching statistical differences for CD4+ 
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Fig. 38: LsAg treatment increases adiponectin concentration in serum and IL-10 in adipocyte 
supernatants, respectively. Adiponectin levels in adipose tissue supernatant (A) and serum (B) as well as IL-
10 in adipocyte supernatant (C) of animals receiving a chow diet (NFD) and treated with PBS and high-fat diet 
(HFD) 16 weeks-fed animals that were treated daily for 2 weeks i.p. with LsAg. Results are shown as mean + 
SEM. Differences were analyzed for statistical significance using by two-tailed non-parametric Mann-
Whitney-U-test (A, C) and Kruskal-Wallis followed by the Dunn’s multiple comparison test (B). Data shown 
are pooled from two independent experiments with 6 mice per group. 
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IFN-γ cultured with LsAg (Fig. 39A), CD4+ TNF+ (Fig. 39B) and CD4+ IL-17+ (Fig. 39C). 
Frequencies of CD8+ T cells producing IFN-γ (Fig. 39D), TNF (Fig. 39E) and IL-17 (Fig. 
39F) were significantly decreased in the presence of LsAg adipocyte-conditioned media 
compared to HFD PBS-treated adipocyte media. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus, LsAg conditioned adipocyte media showed marked anti-inflammatory properties and 
elevated levels of Acrp30 in serum and IL-10 in adipocytes, which correlated with decreases 
in the frequency of CD4+ and CD8+ T cells producing IFN-γ, TNF and IL-17.  
Subsequent experiments were performed by Jayagopi Surendar from our group and revealed 
that induction of IFNγ+ and IL-17+ T cells is inhibited by adiponectin (Surendar, Frohberger 
et al., manuscript submitted).  
Fig. 39: Adipocyte conditioned media from LsAg treated mice reduces CD4+ and CD8+ T cell inflammation 
in vitro. Splenic CD4+ T cells and CD8+ T cells from HFD mice cultured in the presence of adipocyte conditioned 
media from mice treated with PBS and high-fat diet (HFD) fed animals for 16 weeks that were treated daily for 2 
weeks intraperitoneal with PBS or LsAg. Frequencies of IFN-γ+ (A), TNF+ (B) and IL-17+ CD4+ T cells (C) as 
well as frequencies of CD8+ T cells IFN-γ+ (D), TNF+ (E), IL-17+(F). Results are shown as median. Differences 
were analyzed for statistical significance using Kruskal-Wallis followed by the Dunn’s multiple comparison test 
.*p<0.05, **p<0.01. Data shown are pooled from two independent experiments with 3 mice per group. 
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4. Discussion 
In this thesis protective immune responses against the filarial nematode L. sigmodontis and 
the impact of filariae-derived products on diet-induced insulin resistance were analysed. In the 
first part of the thesis the type 2 cytokine pathways of IL-4 and IL-5 as well as eosinophils 
were directly compared for their impact on L. sigmodontis infection in susceptible BALB/c 
mice.  
4.1 Role of IL-4R, IL-5, IL-4R/IL-5 and eosinophils during L. sigmodontis infection 
L. sigmodontis infection was compared in mice deficient for IL-4R, IL-5, IL-4R/IL-5 and 
eosinophils. Since IL-4R is essential for the development of AAMs and IL-5 for eosinophil 
differentiation and survival, parasitological results were correlated with those two cell types 
[182]. Several studies have confirmed a crucial role for IL-4, IL-4R and IL-5 during L. 
sigmodontis infection and that the absence of IL-4 signaling resulted in increased MF levels 
and extended microfilaremia in BALB/c mice. Furthermore, the lack of IL-5 led to an 
increased worm burden and an enhanced worm survival [183]. In addition, it has been shown 
that L. sigmodontis infection triggers an eosinophilia, which contributes to adult worm 
clearance [182, 213]. Results of this study demonstrate that L. sigmodontis-infected immune-
compromised mice (IL-4R-/-, IL-5-/-, IL-4R-/-/IL-5-/-) exhibited increased and extended 
microfilaremia compared to corresponding WT animals and confirmed previous studies [183, 
199, 214]. Our findings further demonstrate that the absence of IL-5 and eosinophils, rather 
than IL-4R impair essential immune responses, leading to increasing MF levels. Highest MF 
loads were observed in IL-4R-/-/IL-5-/- mice. The MF load in mice lacking eosinophilia (IL-5-/-
, IL-4R-/-/IL-5-/-, dblGATA) were increased and sustained for an extended period of time, 
which was associated with a prolonged adult worm survival and therefore, probably an 
extended period of MF release. Absence of eosinophils (dblGATA), IL-4R and IL-4R/IL-5 
led to an increased microfilaremia in 100% of the tested animals.  
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Interestingly, IL-5 deficient mice did not exhibit such increased patency compared to WT 
controls, indicating a divergent phenotype between dblGATA and IL-5-/- mice. Besides, 
correlation analysis between thoracic cavity eosinophils and adult worm burden at 71dpi 
revealed a strong negative correlation, confirming previous results for the essential protective 
role of eosinophils during filariasis [182, 213]. Such an interrelation between extended adult 
worm survival and prolonged microfilaremia was shown by Volkmann et al. for L. 
sigmodontis-infected IL-5 deficient mice [183]. Injected MF led to a comparable clearance in 
WT, IL-4 and IL-4R deficient mice, whereas survival in IL-5 lacking mice was extended 
[183]. Previous studies showed that the spleen is essentially involved in the MF clearance and 
future studies should therefore investigate the impact of the spleen in IL-5 deficient and 
dblGATA mice in the clearance of MF [174, 215]. On the other hand, all the knockout mouse 
strains used in this study exhibited enlarged spleens compared to WT controls, which were 
associated with increased MF levels and extended MF survival in the immune-deficient mice 
over time. Our results further suggest, that the elevated MF production is due to the enhanced 
fertility in the female worms residing in knockout mice (dblGATA, IL-5-/-, IL-4R-/-/IL-5-/-), 
revealing elevated numbers of eggs, morulaes, pretzels and MF. Interestingly, the onset of 
microfilaremia was observed earlier in IL-4R-/- mice, whereas eosinophil deficient dblGATA 
and IL-5-/- mice had a comparable onset of microfilaremia compared to WT mice. However, 
another study demonstrated, that helminth development is dependent on immunological 
pressure and therefore the absence of essential immunological factors such as IL-5, impairs 
worm development [216].  
Female worm lengths in all immune-deficient mice were significantly increased during 
chronic L. sigmodontis infection at 71dpi, whereas differences in worm length were not 
observed at 119dpi, demonstrating an accelerated filarial development and embryogenesis by 
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an increased number of eggs, morulaes, pretzels and MF’s in the absence of IL-4R, IL-5 and 
eosinophils.  
Another report has shown contrary results, suggesting that the L. sigmodontis larvae 
development into the L4 stage is delayed in the absence of IL-5. Therefore, co-administration 
of recombinant IL-5 with L3 inoculation abrogated this impaired larvae development leading 
again to an earlier onset of microfilaremia and an increased MF load. [216].  
The underlying reason behind these diverse results may be the host background, since we 
used susceptible BALB/c mice, whereas semi-resistant C57BL/6 mice were used in the 
Babayan study. In addition, different infection time points were analysed. Therefore, future 
studies should focus on the extent host background and exposure time to eosinophils/IL-5, 
which may affect L. sigmodontis development.  
IL-4R is essential for the development and expansion of AAMs in the thoracic cavity of L. 
sigmodontis-infected mice [200] and lack of AAMs in IL-4R-/- and IL-4R-/-/IL-5-/- resulted in 
a reduced total number of thoracic cavity macrophages. A negative correlation was observed 
between thoracic cavity AAM numbers and the MF load at 71dpi and AAMs were associated 
with a delayed onset of microfilaremia. Th2 cytokines (IL-4, IL-5, IL-13) within the thoracic 
cavity did neither correlate with the adult worm burden nor MF counts. Solely IL-6 negatively 
correlated with the MF counts on 71dpi.  
Recently, a protective role of IL-6 against invading L3 larvae was shown, which resulted in an 
increased adult worm burden at early time points of infection in IL-6 deficient mice [217]. 
However, after the molting into adult worms, the worm burden and MF loads did not differ 
between IL-6 deficient and corresponding WT mice any longer, indicating no direct impact of 
IL-6 on MF loads. 
Increased IFN-γ levels were observed during the chronic and late phase of L. sigmodontis 
infection in all tested immune-compromised mice, suggesting that either increased MF loads 
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trigger type 1 immune responses or lack of a part of the type 2 immune responses drives IFN-
γ responses. In regard to the induction of IFN-γ responses by MF, Hübner et al. showed that 
IFN-γ responses were increased after the injections of MF into naïve animals [218]. IFN-γ 
levels may contribute to adult worm clearance, which is supported by a study analysing IFN-γ 
deficient mice, which exhibited an impaired neutrophil-mediated removal of L. sigmodontis 
adult worms and increased MF levels [219]. Furthermore, neutrophil numbers within the 
spleen correlated positively with the adult worm burden and MF load. 
In summary, findings of this project indicate that the combined lack of eosinophils and AAMs 
in IL-4R-/-/IL-5-/- increased susceptibility for L. sigmodontis infection, which led to an earlier 
onset of microfilaremia, development of microfilaremia in 100% of the tested animals, 
highest MF loads and an extended adult worm survival. 
Considering these data, IL-4R-/-/IL-5-/- mice may be used for infections with human 
pathogenic filariae due to their high susceptibility. Accordingly, Tendongfor et al. showed 
that the human pathogenic filariae Loa loa survived up to 70 days after L3 inoculation in IL-
4R-/-/IL-5-/- mice and completed molting into immature adult worms [220]. Furthermore, IL-
4R-/-/IL-5-/- mice may represent an interesting animal model for the screening of potential 
macrofilaricidal and microfilaricidal drug candidates. They possess an extended adult worm 
survival and increased microfilaremia which allows the identification of slow acting active 
compounds against adult worms or MF, during the onset of microfilaremia or before the 
development of microfilaremia as a prophylactic treatment. Furthermore, lack of eosinophils 
and AAMs allows the investigation of potential interactions between these cell types and drug 
candidates or the requirement of an intact host immune system. 
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4.2 Anti-inflammatory properties of S100A8/A9 during L. sigmodontis infection 
Parasitic filarial nematodes modulate the host immune system to their benefit to evade 
specific immune responses during early and chronic phases of infection and therefore, 
enhance parasite maintenance and survival within the host. Several studies confirmed 
inflammatory [132] and anti-inflammatory properties [149] of S100 calgranulin proteins. 
However, little is known about their role during filarial infection. S100A8/A9 was shown to 
be abundant in almost 20% of murine neutrophil granula and 45% of human neutrophil 
granula [221], exhibiting chemotactic properties on neutrophils [222]. Since an increased 
expression of S100A8/A9 within the lung was found during L. sigmodontis L3 larvae 
migration [131], the impact of S100A8/A9 on neutrophils and on L. sigmodontis infection 
was investigated. 
During the migration of invading infective L3 larvae an increased inflammatory response 
within the thoracic cavity and BAL was observed in S100A8/A9-/- mice, which was 
furthermore associated with an increased neutrophil activation in S100A8/A9-/- animals. 
Karadijan and colleagues revealed a pulmonary phase during L. sigmodontis L3 migration in 
susceptible WT BALB/c mice, which was characterized by increased lung pathology, 
resulting in inflamed endothelium and parenchyma as well as an elevated number of 
neutrophils and elevated expression of S100A8/S100A9 [131]. Similar results were observed 
in C57BL/6 WT mice that were used as control for the S100A8/A9-/- mice in this thesis. 
Analysis of the worm burden revealed a significantly decreased worm burden in S100A8/A9-/- 
animals compared to WT controls following natural and subcutaneous infection, which was 
further associated with a higher chemokine production, granulocyte recruitment and 
neutrophil activation in the BAL as well as chemokine production in the thoracic cavity 
lavage. 
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The previously described data indicate that S100A8/A9 dampens transient pulmonary 
inflammation, caused by the migration of infective L. sigmodontis L3 larvae. Various studies 
confirmed multifunctional properties of S100A8 and S100A9, which may differ depending on 
the inflammatory milieu. Calprotectin interacts with TLR4, which represents one of the main 
receptors for S100A8/S100A9 [135, 136, 223, 224] and is expressed on various innate 
immune cells. A recent study showed that TLR4-/- animals exhibited no differences in the 
adult L. sigmodontis adult worm and MF burden compared to WT controls [225]. However, 
the deficiency of TLR4 led to an increased frequency of MF positive animals compared to 
WT controls. It is possible that S100A8/A9 may interact with RAGE during L. sigmodontis 
infection, leading to a different phenotype as was observed in TLR4-/- animals [225]. Whether 
RAGE deficient mice have a similar phenotype as S100A8/A9-/- animals should be part of 
future analysis, since RAGE represents another main receptor for S100A8/A9. 
In contrast to previous studies, which demonstrated a S100A8 and S100A9 involvement in the 
recruitment of murine and human phagocytes to the site of inflammation, S100A8/A9-/- mice 
revealed increased frequencies of neutrophils within the bronchoalveolar lavage upon L. 
sigmodontis infection. This was associated with increased concentrations of CXCL-1, CXCL-
2, CXCL-5, and elastase in the thoracic cavity and bronchoalveolar lavage of S100A8/A9-/- 
indicating that S100A8/A9 may exhibit anti-inflammatory properties during filarial infection. 
Therefore, those results are in contrast to previous studies showing a neutrophil-recruiting 
feature of S100A8 and S100A9 and that the injection of S100A8 into the mouse foot pad 
leads to an increase of neutrophils within the first 4-6 hours, followed by monocytes over 24 
hours [226]. However, potential anti-inflammatory properties of calprotectin are supported by 
a murine experimental colitis model, where calprotectin given by the intrarectal route led to 
less tissue damage, decreased MPO activity as well as TNF production [149]. 
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Numerous studies have confirmed protective features of neutrophils during fungal, bacterial 
and helminth infections by phagocytosis, generation of reactive oxygen species (ROS) [138], 
degranulation and formation of NETs [150]. Similarly, our group showed that impaired 
neutrophil recruitment during L. sigmodontis infection in NOD2-/- mice results in reduced 
inflammatory immune responses within the skin and therefore facilitates L3 migration and 
leads to an increased worm burden [227]. In contrast to these results, the findings described in 
this thesis demonstrate a novel protective role of S100A8/A9-/- neutrophils during the 
pulmonary migration of L. sigmodontis L3 larvae, since circumventing the skin barrier by s.c. 
infection of L. sigmodontis L3 larvae led to a similar decreased worm burden in S100A8/A9-/- 
mice. Depletion of pulmonary neutrophils of S100A8/A9-/- animals during the migratory 
phase of L. sigmodontis (2-6 dpi) on the other hand abrogated the observed protective effect 
and resulted in an increased worm burden compared to isotype-treated S100A8/A9-/- and WT 
mice. 
Bone-marrow-derived neutrophils of S100A8/A9-/- mice exhibited an increased ex vivo and in 
vitro activation, which contributed to an inflammatory milieu and may support the elimination 
of infective L3 larvae in the lung. Furthermore, the increased neutrophil activation observed 
in S100A8/A9-/- mice was associated with an increased apoptosis, which could explain the 
elevated levels of S100A8/A9 in the BAL during L. sigmodontis infection [131]. L3 larval 
motility was significantly inhibited in the presence of S100A8/A9-/- neutrophils compared to 
WT neutrophils in a DNA and NET formation dependent manner. Additional factors such as 
granula proteins (cathepsin G, proteinase 3) or enzymes like MPO, elastase, may be involved 
in the parasite motility inhibition as well. Collectively, these results demonstrate a pulmonary 
role of S100A8/A9 that dampens inflammatory responses within the lung caused by the 
migration of L3 larvae, decreasing granulocyte recruitment, chemokine production as well as 
neutrophil activation ex vivo and in vitro and therefore facilitating larval migration. 
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In summary, mice deficient for calprotectin exhibited a significantly reduced L. sigmodontis 
worm burden compared to WT controls, which vanished and led to an increased worm 
burden, during the depletion of neutrophils from S100A8/A9-/- mice within the lung prior to L. 
sigmodontis infection until 5dpi. Considering these findings, S100A8/A9 should be 
investigated in human pathogenic nematodes such as Necator americanus, Ancylostoma 
duodenale [228], Strongyloides stercoralis [229], and Ascaris lumbricoides [230], which all 
share a common passage through the pulmonary vasculature and respiratory epithelium [231]. 
Therefore, infection with Nippostrongylus brasiliensis, which represents a model for human 
hookworm infection in S100A8/A9-/- mice could lead to new insights and understanding of 
protective immune responses during the lung stage of infection [232-234]. 
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4.3 Role of Aryl hydrocarbon receptor during L. sigmodontis infection 
AhR, a member of the PRRs, is highly expressed on mature immune cells at barrier sites such 
as lung, liver, gut [154] and skin [152, 153]. The receptor represents an essential component 
of the immune system for the recognition of external danger signals and orchestrates specific 
immune responses against invading pathogens. Ajendra and colleagues showed that the 
absence of another prominent member of the PRR family, the nucleotide-binding and 
oligomerization domain-containing protein 2 (NOD2)-like receptors (NLRs), led to an 
impaired neutrophil recruitment within the skin and to an increased worm burden during the 
early phase of L. sigmodontis infection [227]. However, still less is known about the role of 
AhR during filarial infections. Therefore, the impact of AhR which is highly expressed within 
the skin, a barrier traversed by infective L3 larvae, on L. sigmodontis infection was 
investigated. 
Immune responses within the skin in dependence of AhR were analyzed by i.d. injections of 
crude adult worm extract (LsAg) in AhR-/- and WT animals. Three hours post LsAg injection 
total cell counts as well as total numbers of macrophages, neutrophils and eosinophils within 
the skin of AhR-/- mice were significantly lower and less activated (CD86 ↓ on monocytes, 
MHCII ↓ on macrophages, CD69 ↓ on neutrophils) compared to WT LsAg treated animals. 
As described by Ajendra et al. [227] the decreased frequencies of macrophages and 
eosinophils may be due to the impaired recruitment of neutrophils, since neutrophils represent 
the first cell type to encounter invading pathogens and play a major key role during the 
recruitment of other effector cells to the site of infection [227]. Several studies confirmed 
such an essential key role of neutrophils as the first line of defense against invading larval 
stages from several helminth species, revealing a crucial role in the parasite’s elimination 
against Strongyloides stercoarlis [235] or Trichinella spiralis [236] as well as against 
Schistosoma mansoni [237]. Neutrophils have been further shown to contribute to the 
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formation of inflammatory nodules around adult filariae and therefore accelerate parasite 
elimination [238]. 
The AhR has also been shown to be expressed in Langerhans [239, 240] and dendritic cells 
[241], which may additionally have a crucial impact on the cell recruitment, especially on 
neutrophils. Nevertheless, these assumptions are contrary to a study performed by Cotton et 
al. where no essential involvement of Langerhans and DCs during the migration of B. malayi 
L3 larvae was observed [242]. They failed to be activated by the invading larvae, indicating 
that DCs and Langerhans cells may also not be essential or crucial for the elimination of 
infective L. sigmodontis L3 larvae.  
Interestingly, our results further indicate that deficiency of AhR also impairs immune 
responses at the site of infection, the pleural cavity. Frequencies of CD4+ T cells and 
neutrophils were significantly decreased in the pleural cavity at 5 and 14 days post L. 
sigmodontis infection. Al-Quaoud and colleagues demonstrated a role of CD4+ T cells in the 
controlling of larval L. sigmodontis development, whereupon depletion of CD4+ T cells from 
infected BALB/c mice led to an increased worm and microfilarial burden compared to 
infected controls [181].  
In addition, eosinophilia was diminished in the absence of CD4+ T cells-depleted animals. 
Eosinophils, which have been shown in several helminth studies to contribute to worm 
clearance during chronic infections, were decreased at 14dpi within the pleural cavity lavage. 
Results from this thesis and previous studies demonstrated that the absence of eosinophils for 
instance in dblGATA or IL-5 deficient mice [216] resulted in an increased L. sigmodontis 
worm burden, indicating that adult worms have an survival benefit in AhR-/- mice. 
Another prominent chemokine and prominent indicator for inflammation and autoimmune 
diseases (rheumatoid arthritis, systemic lupus rythematosus, sjogren syndrome, systemic 
sclerosis) is CXCL-10 [243]. CXCL-10, also known as IP-10, was present at increased 
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concentrations within the thoracic cavity lavage at 5 and 14 days post L. sigmodontis infection 
in AhR-/- mice. CXCL-10 has been described to play an important role during the 
chemoattraction of other effector cells such as macrophages [244-247], which may explain the 
increased frequency of macrophages within the thoracic cavity during both time points in 
AhR-/- animals compared to WT controls.  
AhR deficiency and the increased worm burden in AhR-/- mice may also be associated with an 
increased vascular permeability, as such an increased vascular permeability was previously 
shown to lead to an increased worm recovery in CCL17 deficient mice [248]. 
Next to the impaired immune response in the skin and the thoracic cavity, AhR deficiency 
was indeed associated with an increased vascular permeability, which may facilitate L3 
migration and therefore, leading to an increased worm recovery in AhR-/- mice [248]. 
Accordingly, decreased levels of CCL17 at 14dpi within the thoracic cavity and at 5dpi within 
the bronchoalveolar lavage were observed in AhR-/- mice. To confirm that changes in the 
vascular permeability are responsible for the increased worm burden in AhR-/- mice, 
additional analysis of mast cells should be included in future experiments. Mast cell 
degranulation and release of histamine may be the responsible mediators for the enhanced 
vascular permeability, which facilitates L. sigmodontis larval migration within the host. 
Inhibition experiments for mast cell degranulation for instance with cromolyn or histamine 
blockade could be performed to address the impact of mast cell degranulation and histamine 
release as it is the responsible factor for the increased vascular permeability and worm 
recovery in CCL17 deficient mice [248]. 
Taken together, these findings demonstrate that the absence of AhR impairs several potential 
protective immune responses against L. sigmodontis. It impairs immune responses within the 
skin, enhances vascular permeabilization which possibly facilites the migration of infective 
L3 L. sigmodontis larvae and finally reduces protective immune responses in the thoracic 
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cavity, resulting overall in a significantly increased worm burden in AhR-/- mice compared to 
WT animals.  
While several studies confirmed an essential antimicrobial role of AhR [165-169], results 
shown in this thesis demonstrate a novel role of AhR-mediated protective immune responses 
against the filarial nematode L. sigmodontis. Considering the fact that AhR is highly 
expressed in several tissues such as skin [152, 153], lung, liver, and gut [154] 
and AhR-/- mice lack intraepithelial lymphocytes as well as intestinal innate lymphoid cells 
within several barrier organs [170], next approaches may include the investigations of AhR 
during infections with intestinal helminths or species characterized by a lung passage during 
their migration phase. Therefore, the role of AhR in the gut may be investigated via murine 
infection with the gastrointestinal nematode Heligosomoides polygyrus, since this helminth 
does not pass the lung in its migration phase [249]. Findings may improve our understanding 
and the potential involvement of AhR in the initiation of protective immune responses against 
diverse helminths species with different routes of infection. New insights could lead to new 
therapeutic approaches against human helminth parasites, such as Ascaris lumbricoides 
(roundworm), Trichiuris trichiuria (whipworm), Ancylostoma duodenale, and Necator 
americanicus (hookworms) [250].  
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4.4 LsAg dampens T cell inflammation and improves glucose tolerance in diet-induced    
      obese mice 
Due to the immunomodulatory capacity of helminths, recent studies showed that helminth 
infections or the repeated administration of crude adult worm extracts (LsAg) improve 
obesity-induced insulin resistance [117, 118]. Berbudi and colleagues revealed that LsAg 
treatment in 14 weeks HFD fed mice alleviated obesity-associated inflammatory immune 
responses and improved glucose tolerance [118]. Despite these findings less is known about 
the protective mechanisms of helminth-derived immunomodulatory molecules on DIO.  
In this thesis, repeated administrations of LsAg were tested for their potential to lessen DIO 
induced pro-inflammatory T cell responses and their impact to improve glucose tolerance. As 
expected, the body weight of mice, which received HFD for 12-16 weeks were increased 
compared to corresponding NFD mice. HFD impaired glucose tolerance and insulin 
sensitivity compared to lean controls and repeated i.p. administrations of LsAg improved 
glucose tolerance, confirming previous results with LsAg [118]. No improvement of insulin 
sensitivity in DIO mice was observed after LsAg treatment. Interestingly, DIO mice which 
were treated s.c. either with LsAg did not show any improvement on glucose tolerance, 
indicating that a potential depot effect in the s.c. tissue, in which LsAg may be slowly 
released and elicit a prolonged efficacy, has no beneficial effect. Similar results were 
observed in another study using non-obese diabetic (NOD) mice, which spontaneously 
develop T1D. Similarly, s.c. administrations of ES-62-derived SMAs had no beneficial impact 
in reducing the incidence of T1D onset in NOD mice [251].  
In contrast, DBA/1 mice treated s.c. with ES-62 were protected from arthritis in the collagen-
induced arthritis model, which were characterized by a reduced articular score as well as 
inflammatory cell infriltration, cartilage and bone destruction [125].  
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These studies demonstrate the complexity of filarial extracts such as ES-62 and SMAs 
targeting multiple potential targets within the immune system [26, 252, 253] and that these 
multifunctional roles of helminth-derived products and SMAs may differ depending on the 
inflammatory milieu. 
Furthermore, elevated levels of cholesterol, triglycerides and LDLs were observed in HFD 
mice in comparison to lean individuals, confirming that obesity is associated with an 
increased lipid accumulation. Repeated administration of LsAg had no statistically significant 
impact on the lipid profile, indicating that LsAg treatments improve glucose tolerance without 
altering lipogenesis and adiposity.  
Previous studies have shown that obesity is characterized by T cell inflammation [107-109] 
and that helminth infections or helminth-derived products alleviate adipose tissue 
inflammation by inducing type 2 immune responses [118]. Nevertheless, not much is known 
about their impact on DIO T cell inflammation. As expected, obesity increased the 
frequencies of IFN-γ+ and IL-17+ T cells in adipose tissue from DIO mice compared to NFD 
mice, which is in accordance with the study of Winer et al., revealing elevated frequencies of 
IFN-γ+ CD4+ T cells in adipose tissue and IL-17+ CD4+T cells in spleen during obesity 
[110]. Observed elevated frequencies of adipose tissue TNF+ CD4+ T cells, IFN-γ+ CD8+ T 
cells, TNF+ CD8+ T cells and IL-17+ CD8+ T cells in our study are in contrast to the results 
from Winer et al. [110]. Divergences may be due to differences in the duration of the 
administered HFD treatment, as in our project animals received a prolonged HFD (16 weeks) 
compared to the study performed by Winer and colleagues (8 weeks).  
Repeated LsAg administration in DIO mice decreased the frequency of TNF+, IFN-γ+ and 
IL-17+ adipose tissue CD4+ T cells and TNF+ as well as IL-17+ CD8+ T cells compared to 
HFD PBS-treated mice. Thus, repeated administrations of LsAg reduced obesity-associated T 
cell inflammation within the adipose tisse during the onset of obesity. However, whether pro-
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inflammatory CD8+ T cells are indeed contributing to local adipose tissue inflammation 
during obesity is still controversally discussed. Nishimura et al. demonstrated that adipose 
tissue inflammation and insulin resistance is improved in CD8+ T cell deficient mice and 
following CD8 antibody depletion [107]. However, another report showed that the transfer of 
CD8+ T cells into T cell deficient RAG1, which received HFD, do not contribute or worsen 
adipose tissue inflammation [110]. Thus, additional studies are required to investigate, 
whether CD8+ T cells contribute to adipose tissue inflammamtion and insulin resistance and 
whether the reduction of those pro-inflammatory CD8 T cells by helminth product treatment 
is mediating the observed improvement in glucose tolerance.  
In regard to the mechanisms by which obesity-induced CD4 and CD8 T cell inflammation is 
inhibited by helminth products, the impact of Acrp30, an essential mediator of metabolic 
homeostasis in adipose tissue was investigated. Acrp30 represents a protein hormone, which 
is produced by adipocytes and circulates in the bloodstream. It has been shown to be involved 
in numerous pathways and modulates metabolic processes, such as glucose regulation and 
fatty acid oxidation [126, 127].  
A recent report demonstrated that Acrp30 in combination with leptin reverses insulin 
resistance in mice [128]. Further studies have also shown an inverse correlation between 
obesity and Acrp30 concentrations [127, 129, 130]. Acrp30 levels within the serum of LsAg-
treated HFD animals were increased compared to PBS-treated HFD controls. Although the 
difference did not reach statisctical significance in this thesis, subsequent experiments that 
were performed by Dr. Surendar confirmed an increased adiponectin concentration in serum 
and adipocyte supernatant of LsAg treated animals and demonstrated that the inhibition of 
Th1 and Th17 cells is mediated via adiponectin (Surendar, Frohberger et al., manuscript 
submitted). Furthermore, results from this thesis indicate that repeated administration of LsAg 
increased IL-10 concentrations within the adipocyte supernatant, which may contribute to the 
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counter regulation of adipose tissue inflammation. For that reason future experiments should 
include neutralisation experiments to investigate and to verifiy, if the observed protective 
effect caused by LsAg may be also dependent on IL-10. 
Data shown in this thesis indicate that LsAg improve glucose tolerance and counterregulate 
DIO adipocyte T cell inflammation highlighting that LsAg or filarial extracts contain new 
promising candidates that should be further persued to target obesity induced glucose 
intolerance and adipose tissue inflammation. Various human studies indicate that helminth 
infections may improve insulin sensitivity in humans. Nevertheless, the investigations of the 
underlying beneficial mechanisms of helminth infections using animal models are still rare 
[115, 116, 254, 255] and the contribution of helminth-derived molecules is not completely 
understood. Next experiments should further concentrate on the impact on metabolic changes 
in the liver and energy metabolism including pancreatic β-cell function, glucose uptake into 
muscle cells, insulin resistance of target organs, glucose formation in the liver, release of fatty 
acids in adipose tissue as well as detection of insulin in the brain. 
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Complimentary projects 
Identification of macrofilaricidal substances 
The elimination of onchocerciasis (river blindness) [44] and lymphatic filariasis 
(elephantiasis) [8] is hampered by the lack of macrofilaricidal drugs. Current programs rely 
on the microfilaricidal drugs DEC, IVM and ALB, which require an annual to bi-annual 
treatment for the reproductive life span of the female adult worms and harbour the risk to 
cause severe adverse events in Loa loa patients [8, 35]. Wolbachia, an essential bacterial 
endosymbiont of nematodes have been successful validated as new promising target for anti-
filarial therapy [60, 78, 79, 82]. 
Within a collaboration of industry, non-profit organizations (Drugs for Neglected Disease 
initiative and Bill & Melinda Gates Foundation) as well as partners from Universities, new 
macrofilaricidal drug candidates were identified. As part of my PhD thesis I was involved in 
the efficacy testing of the clinical candidates AWZ1066 (LSTM, EISAI), ABBV-4083 
(Abbvie), AN11251 (Anacor), CBR417 and CBR490 (Calibr) in the L. sigmodontis rodent 
model.  
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Complimentary project A- AWZ1066S, a highly specific anti-Wolbachia drug candidate 
for a short-course treatment of filariasis 
W. David Hong, Farid Benayoud, Gemma L. Nixon, Louise Ford, Kelly L. Johnston, Rachel H. Clare, 
Andrew Cassidy, Darren A. N. Cook, Amy Siu, Motohiro Shiotani, Peter J. H. Webborn, Stefan 
Kavanagh, Ghaith Aljayyoussi, Emma Murphy, Andrew Steven, John Archer, Dominique Struever, 
Stefan J. Frohberger, Alexandra Ehrens, Marc P. Hübner, Achim Hoerauf, Adam P. Roberts, 
Alasdair T. M. Hubbard, Edward W. Tate, Remigiusz A. Serwa, Suet C. Leung, Li Qie, Neil G. Berry, 
Fabian Gusovsky, Janet Hemingway, Joseph D. Turner,Mark J. Taylorb, Stephen A. Wardb, Paul M. 
O’Neill. AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of 
filariasis. Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1414-1419. doi: 10.1073/pnas.1816585116. 
Epub 2019 Jan 7. 
 
New screenings identified AWZ1066S as a novel anti-Wolbachia candidate against 
onchocerciasis and lymphatic filariasis. In two independent filarial infection models the 
efficacy of AWZ1066S was tested with a seven-day oral dosing regimen (100mg/kg), which 
resulted in a >90% Wolbachia depletion in female B. malayi infected SCID mice as well as in 
female L. sigmodontis infected gerbils. Similar results were observed in vitro for B. malayi 
MF. Longitudinal effects of AWZ1066S on circulating L. sigmodontis microfilaremia after 1-
18 weeks post treatment further revealed a gradual depletion of MF, suggesting adult 
inhibition of the filarial embryogenesis and potential sterilization. Results of this study 
highlight AWZ1066S as promising pre-clinical drug candidate. Therefore, further clinical 
studies (phase 1-3) are required to confirm its non-toxicity and compatibility in humans. 
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Complimentary project B- Discovery of ABBV-4083, a novel analog of Tylosin A that 
has potent anti-Wolbachia and anti-filarial activity 
Thomas W. von Geldern, Howard Morton, Rick F. Clark, Brian Brown, Kelly L. Johnston, Louise 
Ford, Sabine Specht, Marc P. Hübner, Robert Carr, Deanne Stolarik, Junli Ma, Matt Rieser, 
Dominique Struever, Stefan J. Frohberger, Marianne Koschel, Alexandra Ehrens, Joseph D. Turner, 
Achim Hoerauf, Mark J. Taylor, Stephen A. Ward,  Kennan Marsh and Dale J. Kempf. Discovery of 
ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity. 
PLoS Negl Trop Dis. 2019. Feb 28;13(2):e0007159. doi: 10.1371/journal.pntd.0007159. eCollection 
2019 Feb. 
In another separate study chemical modifications that led to an improved metabolic stability 
of the veterinary antibiotic Tylosin A (TylA) revealed an optimized analogue (ABBV-4083) 
with improved anti-Wolbachia efficacy and oral pharmacokinetic properties. TylA has been 
shown to elicit similar in vitro and in vivo activity as doxycycline against Wolbachia. 
However, the poor oral bioavailability posed a big challenge. The efficacy of TylA and the 
analogue ABBV-4083 was compared and investigated in the L. sigmodontis murine animal 
model. Although, L. sigmodontis infected mice treated i.p. with TylA (twice daily 200mg/kg) 
revealed an impaired worm development, oral treatment of TylA had only minimal efficacy. 
These results were related to differences in the bioavailability of TylA administered i.p. (>30-
fold higher) compared to oral regimens. Promising results were achieved in an in vivo 
experiment with gerbils (Meriones unguiculatus) infected with L. sigmodontis, which were 
treated with ABBV-4083 orally (150mg/kg daily for 14 days). Wolbachia levels were reduced 
by >99.9% until 16 weeks post treatment in the recovered female adult worms, which was 
further accompanied a decline of circulating MF as well as impaired embryogenesis of the 
remaining female worms (decreased numbers of eggs, pretzels, morulae, MF).Collectively, 
the modified analog ABBV-4083, which undergoes currently phase 1 clinical evaluation in 
healthy human volunteers, represents a promising drug candidate for oral regimens for 
onchocerciasis and/or lymphatic filariasis-infected patients. 
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Complimentary project C- Boron-Pleuromutilins as anti-Wolbachia agents with 
potential for treatment of onchocerciasis and lymphatic filariasis 
Robert T. Jacobs, Christopher S. Lunde, Yvonne R. Freund, Vincent Hernandez, Xianfeng Li, Yi Xia, 
David S. Carter, Pamela W. Berry, Jason Halladay, Fernando Rock, Rianna Stefanakis, Eric Easom, 
Jacob J. Plattner, Louise Ford, Kelly L. Johnston, Darren A.N. Cook, Rachel Clare, Andrew Cassidy, 
Laura Myhill, Hayley Tyrer, Joanne Gamble, Ana F. Guimaraes, Andrew Steven, Franziska Lenz, 
Alexandra Ehrens, Stefan J. Frohberger, Marianne Koschel, Achim Hoerauf, Marc P. Hübner, Case 
W. McNamara, Malina A. Bakowski, Joseph D. Turner, Mark J. Taylor, Stephen A. Ward. Boron-
Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and 
Lymphatic Filariasis. J Med Chem. 2019 Feb 7. doi: 10.1021/acs.jmedchem.8b01854. 
 
Pleuromutilins are natural-product antibiotics (discovered in 1950) which elicit antibacterial 
efficacy against various pathogens involved in skin and respiratory tract infections. Numerous 
pleuromutilins were screened, chemically modified and tested for its potency as anti-
Wolbachia drugs. In vitro and in vivo experiments in this study demonstrated AN11251 as a 
potential lead candidate due to its high activity against Wolbachia as well as physiochemical 
and pharmacokinetic characteristics. Performed experiments demonstrated that the treatment 
with AN11251 (orally 25mg/kg, BID) in B. malayi L3-infected SCID mice led to a >99% 
Wolbachia clearance in worms after 14 days of treatment compared to 75.4% in 7 day-treated 
animals. However, efficacy of AN11251 against adult B. malayi worms dosed orally at 25 
mg/kg (BID for 7, 14, 28 days) was moderate and not satisfying, as only 45.5% of the 
Wolbachia load was reduced after 28 days of treatment. In contrast, an excellent efficacy of 
AN11251 was observed in the L. sigmodontis BALB/c mouse model (<99% Wolbachia 
depletion) using a higher concentration of 50mg/kg, BID for 14 or 28 days. 
In summary, AN11251 fulfills all requirements to proceed into the clinical safety evaluation 
studies. 
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Complimentary project D- A single-dose cure for the treatment of lymphatic filariasis 
and river blindness 
Malina A. Bakowski, Reza Kazem-Shiroodi, Renhe Liu, Jason Olejniczak, Baiyuan Yang, Kerstin 
Gagaring, Pamela M. White, Hui Guo, Laura Chappell, Alain Debec, Frédéric Landmann, Ashley K. 
Woods, Nicolas Pionnier, Sean B. Joseph, Mitchell Hull, Wen Xiong, Kelli L. Kuhen, Joseph D 
Turner, Bettina Dubben, Franziska Lenz, Dominique Struever, Alexandra Ehrens, Stefan J. 
Frohberger, Marc P. Hübner, Achim Hoerauf, Jason Roland, Matt S. Tremblay, Peter G. Schultz, 
William Sullivan, Xin-Jie Chu, H. Michael Petrassi, Case W. McNamara. A single-dose cure for the 
treatment of lymphatic filariasis and river blindness. Science Translational Medicine 2019. In 
Press.. 
 
There is an urgent need for novel screening systems characterized by a high-throughput to 
identify potent active ingredients for instance against Wolbachia in order to accelerate the 
drug discovery and finally elimination of lymphatic filariasis and onchocerciasis. The goal of 
the study performed by Bakowski and colleagues was to identify drugs with high anti-
Wolbachia efficacy and shortened treatment duration (<7 days). New potential compounds 
would help to overcome general challenges such as impaired infrastructures, which hinder 
equal and consistent drug distribution. Two quinazoline compounds (CBR417, CBR490) were 
discovered by novel ex vivo (high content imaging screening- Quantification of Wolbachia in 
Brugia pahangi filarial ovaries) and in vivo screening systems. As expected for anti-
Wolbachia candidates, CBR417 and CBR490 have been shown to elicit no effect against Loa 
loa. During the study a total number of 300,368 small molecules were screened for potential 
anti-Wolbachia efficacy, which finally led to the identification of various antibiotics (46%), 
antifungals, antivirals, signal transduction modulators and antineoplastics. CBR417 and 
CBR490 efficacy was assessed in vivo in the murine L. sigmodontis model. Animals were 
treated once a day for a total of 4 days with 60mg/kg. Analysis revealed a Wolbachia 
clearance in adult female worms by 99.96% for CBR417 and 99.80% for CBR490. 
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Interestingly, even 2 single doses of 100mg/kg of CBR417 and CBR490 (weekly once) and 
one regimen of 200mg/kg resulted in an excellent Wolbachia clearance of >99% in L. 
sigmodontis adult female worms. 
Results with CBR417 and CBR490 highlight that it is possible to achieve sufficient 
Wolbachia clearance with a single administration. 
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Complimentary project E- Macrofilaricidal efficacy of single and repeated oral and 
subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds 
Marc P. Hübner, Alexandra Ehrens, Marianne Koschel, Bettina Dubben, Franziska Lenz, Stefan J. 
Frohberger, Sabine Specht, Ludo Quirynen, Sophie Lachau-Durand, Fetene Tekle, Benny Baeten, 
Marc Engelen, Charles D. MackenzieIAchim Hoerauf. Macrofilaricidal efficacy of single and repeated 
oral and subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds. PLoS Negl 
Trop Dis. 2019 Jan 16;13(1):e0006320. doi: 10.1371/journal.pntd.0006320. eCollection 2019 Jan. 
 
Flubendazole (FBZ), a member of the family benzimidazole, is known as a very potent and 
broad-spectrum antihelmintic to treat worm infections in domestic and farm animals. Due to 
its high efficacy against filarial nematodes after s.c. regimen, FBZ represents another 
promising macrofilaricidal drug candidate for onchocerciasis and lymphatic filariasis. 
However, if possible drug candidates should be administered as an oral formulation or a 
single parenteral administration to facilitate therapy implementation in the required 
communities. 
In order to study and improve the efficacy of FBZ, a novel developed bioavailable amorphous 
solid dispersion (ASD) as oral formulation of FBZ was investigated in the L. sigmodontis jird 
model. Chronically infected MF positive animals were treated by different oral and s.c. FBZ 
regimens (Oral: single 40mg/kg, repeated 2, 6 or 15mg/kg for 5 or 10 days) (S.c. single 
injection 2 or 10mg/kg) compared to infected untreated controls. The study demonstrated that 
s.c. administered FBZ was slowly released from the injection site and remained longer within 
the host compared to oral doses, which was characterized by a rapidly absorption and 
clearance of FBZ. S.c. FBZ-treated animals (1x or 5x10mg/kg) resulted in a complete adult 
worm clearance, whereas 10x15mg/kg oral FBZ reduced the adult worm burden by 95% and 
1x40mg/kg and 5x15mg/kg by 85% and 84%, respectively. Interestingly, microfilaremia was 
completely cleared in all s.c. FBZ administered animals (100%) compared to oral FBZ treated 
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(10x15mg/kg, 1x40mg/kg, 5x15mg/kg) jirds (90%) in a dose and duration dependent manner, 
suggesting an excellent macrofilaricidal efficacy of FBZ. Oral treatment was furthermore 
associated with the inhibition of embryogenesis of remaining female adult worms, which was 
also confirmed by histopathological analysis illustrating irreversible damage of the female 
uteri and uterine components. 
Taken together, these results indicate oral and s.c. administered FBZ as a potent 
macrofilaricidal candidate, which impairs filarial embryogenesis and therefore, the release of 
MF.  
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Complimentary project F- Filarial extract of Litomosoides sigmodontis induces a type 2 
immune response and attenuates plaque development in hyperlipidemic ApoE-knockout 
mice 
Constanze Kuehn, Miyuki Tauchi, Roman Furtmair, Katharina Urschel, Dorette Raaz-Schrauder, 
Anna-Lena Neumann, Stefan J. Frohberger, Achim Hoerauf, Susanne Regus, Werner Lang, Atilla 
Sagban Tolga, Stephan Achenbach, Marc P Hübner, Barbara. Dietel. Filarial extract of Litomosoides 
sigmodontis modulates the Th1/Th2 ratio and attenuates plaque development in hyperlipidemic ApoE-
knockout mice. The FASEB Journal. 2019. Feb 26:fj201800947RR. doi: 10.1096/fj.201800947RR. 
 
Atherosclerosis represents a predominant metabolic progressive disease in which arteries 
narrow due to the build-up of plaque. Plaques are formed by the accumulation of cholesterol, 
further lipids and inflammatory cells (Th1 cells, macrophages). Severe course of disease may 
results in stroke, peripheral or coronary artery disease and kidney problems. The aim of the 
study was to investigate the immunomodulatory capacity of L. sigmodontis adult worm 
extract (LsAg) in a mouse model of atherosclerosis with focus on plaque progression and 
vascular inflammation. Such a beneficial effect by helminth infections and helminth-derived 
products has been shown in various autoimmune diseases and inflammatory conditions. 
For the preventive model of initital atherosclerosis, six week-old male ApoE-/- mice were fed 
a high-fat Western-type diet for 12 weeks and from week 5 to 12 animals were i.p. treated at 
weekly intervals with PBS or LsAg (50µg per injection). A second batch of mice (therapeutic 
model) received high-fat diet for 12 weeks followed by additional 12 weeks on a regular chow 
diet as well as weekly LsAg administration (50µg). Repeated LsAg administration delayed 
plaque progression (size ↓) in ApoE-/- mice (therapeutic + preventive approach), which was 
associated with a shift towards a type 2 immune response. LsAg treatment further reduced the 
number of inflammatory cells (classically activated macrophages) and cytokines (IL-18 ↓, IL-
2 ↓, IFN-γ ↓). This was further accompanied with an increased number of regulatory AAMs, 
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Foxp3-expressing regulatory T cells, and elevated levels of TGF-β within the plaque deposits 
as well as eosinophils and AAMs within the peritoneum. 
With respect to immunological changes within the spleen, repeated LsAg administration 
reduced the expression of CTLA-4, IL-12 and TNF and decreased levels of Eotaxin, MCP-1 
and MCP-3 within the serum in ApoE-/- mice, which confirmed the immunomodulatory 
properties of LsAg. Moreover, it was shown that LsAg reduced in vitro monocyte adhesion to 
a human endothelial cell monolayer due to the inhibition of JNK1/2 pathway, which 
represents an essential inflammatory signaling during atherosclerosis. 
Results of this study indicate that LsAg represents an effective experimental therapy against 
atherosclerosis due to its immunomodulatory capacities. 
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